Real-time pulse of financial headlines curated from 2 premium feeds.
| Details | Saved | Published | Title | Source | Tickers |
|---|---|---|---|---|---|
|
2025-11-28 00:00
1mo ago
|
2025-11-27 17:30
1mo ago
|
Leading AI Claude Predicts the Price of XRP, Shiba Inu, PEPE by the End of 2025 | cryptonews |
PEPE
SHIB
XRP
|
|
|
Claude has examined how December could bring sharp moves for XRP, Shiba Inu and Pepe, setting out upside targets, downside risks and ETF-related demand, while Maxi Doge has drawn attention as a presale meme coin offering staking rewards and positioning itself as a successor to Dogecoin.
|
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 17:35
1mo ago
|
Is XRP Price Set for a Rally as Binance Reserves Keep Falling? | cryptonews |
XRP
|
|
|
TLDR
XRP price is currently trading at $2.22 and is testing a key resistance zone. The price action remains within a descending channel that has shaped its movement for months. Technical indicators show strong buying strength as the Stoch RSI signals upside momentum. Sellers continue defending the $2.25 and $2.60 resistance levels with quick rejections. A breakout above $3.13 could shift the broader trend and open the path toward $3.60. XRP price currently tests a major resistance zone as buyers and sellers continue their standoff. The value sits at $2.22, directly under the channel’s upper boundary. Momentum grows as technical indicators show bullish pressure at this level. The XRP price action remains inside a long-term descending channel. However, it now presses firmly against its upper limit. Buyers maintain control near reclaimed support, while sellers defend overhead resistance. The Stoch RSI %K line reads 97.56 while the %D line stays at 90.06, indicating intense buying strength. This setup often supports upward continuation when it forms near key structural points. XRP price has responded with pressure near the $2.22 level as momentum builds. Source: TradingView XRP Price Compresses as Sellers Hold Sellers currently hold the line at $2.25, which acts as the nearest resistance barrier. Each attempt above this level has faced strong rejections. Yet, the XRP price structure continues tightening as pressure builds from below. The next upside target lies at $2.60, where sellers remain active. Above that, a breakout beyond $3.13 would shift the entire structure. This move could open the path toward the $3.60 region if sustained buying follows. The XRP price has tested the ceiling multiple times without confirmation. Still, buyers return at each dip, forming higher bases. This behavior suggests that the market prepares for a decisive reaction soon. Falling exchange reserves tighten supply conditions Binance’s XRP reserves have declined to 2.7 billion, down from nearly 3 billion earlier. Since October, 300 million XRP have left the platform. The steady drain reduces near-term selling pressure. Withdrawals indicate users are choosing long-term storage over trading. This move lowers the available supply on the books. It also creates cleaner price reactions near support and resistance areas. Structured investment routes like ETFs add another dynamic. These channels help facilitate larger institutional participation in XRP markets. As access increases, many holders remove coins from exchanges for secure custody. Lower exchange reserves help reduce volatility around major chart levels. The current XRP price setup benefits from these tightening conditions. It allows price to stabilize as technical patterns evolve. The XRP price continues to attract attention as it tests an important chart zone with shrinking supply conditions across platforms. |
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 17:40
1mo ago
|
Vitalik Buterin Promotes Secure Messaging with Significant Ethereum Donation | cryptonews |
ETH
|
|
|
In a bid to bolster digital privacy solutions, Ethereum co-founder Vitalik Buterin has made a substantial donation of 256 ETH, valued approximately at $480,000 as of November 2025, to foster advancements in encrypted messaging. This strategic move targets enhancing privacy measures in digital communications, emphasizing the importance of metadata privacy and permissionless account creation for future developments in the sector.
|
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 18:00
1mo ago
|
AVAX Reclaims Top 20 Spot as Securitize Chooses Avalanche for EU Securities Platform | cryptonews |
AVAX
|
|
|
Avalanche (AVAX) is back in the spotlight after reclaiming its position among the top 20 cryptos to surpass Hedera (HBAR), just as Securitize secures EU approval to launch the region’s first fully regulated blockchain-based securities market on the Avalanche network.
This convergence of regulatory momentum, institutional adoption, and renewed technical strength has positioned AVAX for a potential market revival heading into 2026. AVAX's price trends to the downside on the daily chart. Source: AVAXUSD on Tradingview Securitize Wins EU Approval and Selects Avalanche for Settlement System Securitize received regulatory authorization from Spain’s National Securities Market Commission (CNMV) to operate a tokenized trading and settlement system under the EU’s DLT Pilot Regime. The approval enables Securitize to passport the license across the European Single Market, including France, Germany, and Italy, creating an unprecedented bridge between its U.S. broker-dealer operations and Europe’s capital markets. The firm confirmed that the entire infrastructure will run on the Avalanche blockchain, citing sub-second finality, regulatory-grade network performance, and scalable architecture. This move positions Avalanche at the center of institutional tokenization just as Securitize prepares for a $1.25 billion SPAC merger and expands its portfolio, including managing the now-over $1 billion BlackRock BUIDL on-chain treasury fund. The first EU-compliant issuance is slated for early 2026, opening the door for a wave of regulated tokenized assets, an estimated $18 trillion market by 2033. AVAX Price Holds Key Support as Technical Signals Improve While fundamentals surge, AVAX’s price remains compressed near the long-term support zone around $12–$15. The token recently bounced to $14.94, posting a 6.5% daily gain and breaking above its 7-day moving average at $13.96. It now faces a technical showdown with resistance at the 20-day SMA at $15.21. Momentum indicators are turning constructive. RSI sits at a healthy 42, MACD shows bullish divergence, and Stochastic momentum favors buyers. A breakout above $15.21 could open the path toward $18.61, with a larger target near $33 if long-term trendlines snap. However, failure to hold above $13.91 risks retesting deeper support near $12.57. Institutional Accumulation Strengthens Bullish Outlook Fueling optimism, AVAX One Treasury recently accumulated over 9.37 million AVAX, spending $110 million between November 5 and 23. Total reserves now exceed 13.8 million AVAX, signaling robust long-term institutional confidence. On-chain metrics support the bullish case. Deployed contracts are rising, developer activity is expanding, and futures taker data shows increasing buyer dominance. These combined forces suggest that AVAX may be carving out a medium-term bottom. As institutional momentum builds and Europe’s first regulated blockchain securities market goes live on Avalanche, AVAX’s comeback narrative is gaining traction—and a trend reversal may be closer than the charts imply. Cover image from ChatGPT, AVAXUSD on Tradingview |
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 18:00
1mo ago
|
How AAVE maintains $100M yearly revenue despite $60B DeFi wipeout | cryptonews |
AAVE
|
|
|
Journalist
Posted: November 28, 2025 Key Takeaways How is AAVE performing amid broader DeFi market turbulence? Despite $10 billion in outflows and a 40% annual price drop, AAVE continues to generate over $100 million in annual revenue. What needs to happen for the altcoin to regain momentum? The altcoin must break above the $190 resistance level. Its steady revenue supports a potential rebound if market sentiment improves. The market FUD hasn’t spared the DeFi ecosystem. According to DeFiLlama, investors withdrew nearly $60 billion across protocols, pushing total TVL down to early-July levels of around $120 billion. Aave [AAVE] was no exception, seeing about $10 billion in outflows. And yet, AAVE is still generating over $100 million in annual revenue, with weekly revenues averaging about $3 million, highlighting the protocol’s resilience despite market turbulence. Source: DeFiLlama Notably, its latest income statement reports the highest five-year revenue, and total fees reached $740 million, proving that activity on the platform remains strong despite broader DeFi outflows. In short, AAVE holds strong. Even as the broader DeFi market loses billions, the protocol continues to generate substantial revenue and maintain robust fee activity, cementing its position as one of the most resilient platforms in the space. Resistance remains heavy as AAVE momentum stalls AAVE’s technical structure reflects the broader market FUD. Quarterly, the token is down over 30%. Yearly, it stands out as one of the weakest performers among major DeFi assets, sliding nearly 40%. This puts AAVE in a vulnerable spot heading into the year-end. And while the protocol’s fundamentals look solid, the chart isn’t reflecting it. On the daily timeframe, flipping the $190 resistance won’t be easy. Momentum is still soft, and buyers haven’t shown enough conviction yet. Source: TradingView (AAVE/USDT) Going forward, AAVE needs a break above resistance to flip momentum. In this context, its strong fundamentals come into play. Revenue remains steady, and the protocol still sits at the center of DeFi’s lending stack. That level of consistency is rare in a market dealing with heavy FUD. If the market stabilizes and risk appetite returns, AAVE is one of the few DeFi tokens with the fundamentals to rebound quickly. Until then, the protocol’s revenue keeps it firmly on investors’ radar. Ritika Gupta is a Financial Journalist and Geopolitical Analyst at AMBCrypto, specializing in the critical intersection of world politics, economic policy, and the cryptocurrency markets. Her analysis is informed by her distinguished background, which includes professional experience at major news network. She holds a Bachelor's degree in Political Science and Psychology from Gargi College, University of Delhi. This academic training provides her with a sophisticated framework for dissecting complex issues such as international regulations, government fiscal policies, and the geopolitical forces that directly influence asset valuations. At AMBCrypto, Ritika applies this expert lens to synthesize macroeconomic data and political developments, offering readers a deeper context for market movements. She excels at explaining not just what is happening in the market, but why it is happening. Her work is dedicated to providing strategic insights that empower readers to understand the complex relationship between global events and their digital assets. |
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 18:00
1mo ago
|
MegaETH refunds all $500M after ‘sloppy' pre-deposit campaign | cryptonews |
MEGA
|
|
|
Journalist
Posted: November 28, 2025 Key Takeaways Why is MegaETH refunding all pre-deposit campaign funds? MegaETH announced on 27 November that it will return all $500 million raised in its chaotic 25 November pre-deposit bridge campaign, admitting that “execution was sloppy.” What happens next for depositors and the USDm bridge? All depositors will receive full refunds through a new smart contract currently under audit, with the team promising that contributions “will not be forgotten.” MegaETH has pulled the emergency brake on its disastrous pre-deposit campaign, announcing on 27 November that it will refund all $500 million raised just two days earlier in what the team now admits was a “sloppy” execution plagued by operational failures. Source: X The decision represents a complete reset for the project, which saw its 25 November bridge launch descend into hours of crashes, cap changes, and accusations of mismanagement—culminating in approximately $500 million locked across multiple waves of deposits marked by technical errors and communication breakdowns. “Execution was sloppy” – Team admits failures In a candid Twitter thread, MegaETH acknowledged the fundamental problems with the campaign: “Execution was sloppy and expectations weren’t aligned with our goal of preloading collateral to guarantee 1:1 USDm conversion at mainnet.” The admission comes after the 25 November launch featured: Site crashes that left the bridge down for an hour A $250M cap that filled in 156 seconds, locking out most retail participants A catastrophic multisig error where the team accidentally set 4/4 signature requirements instead of 3/4 User @chud_eth executing the transaction 34 minutes early after spotting the blunder Multiple emergency cap adjustments [$1B → $400M → $500M] as the team scrambled to regain control Community sentiment split approximately 60/40 bearish at the time, with critics calling it a “clown show” while defenders pointed to the “insane demand” that locked half a billion dollars in a bear market. Compliance concerns drive decision The refund announcement includes a telling detail that suggests regulatory or legal pressure influenced the decision: “All comms, however, need to follow compliance standards. [i.e. ‘we must adhere to best practices in our disclosures at this juncture’].” The parenthetical disclaimer—written in stilted legal language—strongly suggests MegaETH received advice that the chaotic launch exposed the project to regulatory risk, particularly around: Inadequate disclosure of terms and risks Last-minute changes to caps without proper communication Potential securities law implications of the pre-deposit structure By resetting and promising improved “compliance standards” and “best practices in disclosures,” MegaETH appears to be attempting to avoid potential enforcement action or investor lawsuits. The path forward The team still has the mainnet targeted for December, but the pre-deposit chaos raises questions about whether they’re ready. For now, depositors await the audited refund contract and hope their funds return “shortly.” Whether they’ll trust MegaETH enough to deposit again when the bridge reopens remains to be seen. |
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 18:01
1mo ago
|
XRP Price Prediction: ETF Inflows Aren't Helping – Is Something Seriously Wrong With Ripple Right Now? | cryptonews |
XRP
|
|
|
Despite a flood of institutional interest, the XRP price prediction remains uncertain as the token struggles to react meaningfully to a wave of new ETF launches.Over six XRP-linked ETFs have debuted in recent days, with combined assets nearing $800 million — yet XRP has posted just a 3% gain in the past week.
|
|||||
|
2025-11-28 00:00
1mo ago
|
2025-11-27 18:10
1mo ago
|
Bitcoin Downtrend Driven by Early Whale Selling, Says Ki Young Ju | cryptonews |
BTC
|
|
|
Bitcoin’s sharp correction from $110,000 to around $80,000 is linked to heavy selling by early whales with cost bases near $16,000. CryptoQuant CEO Ki Young Ju notes that on-chain metrics indicate Bitcoin is now in the “shoulder” phase of its cycle, suggesting limited short-term upside potential.
This selling is overwhelming institutional demand from ETFs and MicroStrategy, shaping the cryptocurrency’s 2025 outlook. In an interview with Upbit’s Upbitcare, Ju provides a data-driven look at the shifting landscape for Bitcoin investors and the forces affecting its current market structure. Early Bitcoin Whales Fuel Selling PressureKi Young Ju explains that today’s market is shaped by a contest between two main whale groups. Legacy whales, holding Bitcoin with an average cost basis near $16,000, have begun to realize hefty profits, selling at a rate measured in hundreds of millions of USD each day. This persistent selling has exerted intense downward pressure on Bitcoin’s price. Sponsored Sponsored At the same time, institutional whales via spot Bitcoin ETFs and MicroStrategy have accumulated significant positions. Yet, their buying power has not matched the scale of early whales’ sell-offs. According to Ju, wallets holding over 10,000 BTC for more than 155 days typically have an average cost basis of around $38,000. Binance traders entered positions around $50,000, so many market participants are in profit and can sell if needed. Cost basis comparison across different Bitcoin holder categories. Source: CryptoQuantThe CryptoQuant CEO points out that spot ETF and MicroStrategy inflows had boosted the market earlier in 2025. However, those flows have now declined. Outflows have started to dominate the market landscape. For example, data from Farside Investors showed Bitcoin ETFs recorded $42.8 million in net inflows on November 26, 2025, lifting cumulative inflows to $62.68 billion. Despite these figures, the sustained selling from early whales outweighs institutional accumulation. Market Cycle Analysis Signals Limited UpsideOn-chain profit-and-loss metrics offer crucial insights into market cycles. Ju’s analysis using the PnL index with a 365-day moving average reveals that the market has entered a “shoulder” phase. This late-cycle status indicates constrained growth potential and increased risk of a correction. The valuation multiplier reflects a neutral-to-flat outlook. In previous cycles, each new dollar drove amplified market-cap growth. Now, that multiplier effect has faded. This suggests market leverage is less efficient, and the structure does not support significant gains. PnL index showing Bitcoin’s current cycle position. Source: CryptoQuantJu does not expect a dramatic 70-80% crash. Still, he considers corrections up to 30% reasonable. A drop from $100,000 could mean Bitcoin falling to about $70,000. He uses data from OKX futures long-short ratios, exchange leverage ratios, and buy-sell flow patterns to support this view. Ju underscores the importance of a data-driven approach. In a recent post, he urged traders to use metrics for conviction, not speculation. His focus remains on interpreting on-chain data, exchange activity, and market structure. This comprehensive analysis provides a grounded assessment based on on-chain evidence. As early Bitcoin whales continue to sell at profits, institutions face a harsh climate. With high leverage ratios, neutral valuation multipliers, and a late-cycle stance, the market has limited potential for a major rally in the near future. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 16:50
1mo ago
|
Grafton Resources Announces Closing of Non-Brokered Private Placement of Units | stocknewsapi |
PMSXF
|
|
|
VANCOUVER, BRITISH COLUMBIA, November 27, 2025 – TheNewswire - GRAFTON RESOURCES INC. (CSE: GFT; OTCQB: PMSXF) (“Grafton” or the “Company”) is pleased to announce that it has closed its non-brokered private placement previously announced on October 28, 2025 (the “ Offering ”), raising aggregate gross proceeds of $2,400,000 via the issuance of 4,800,000 units (each, a “ Unit ”) of the Company at a purchase price of $0.50 per Unit. Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole warrant, a “ Warrant ”). Each Warrant entitles the holder to purchase one common share (a “ Warrant Share ”) of the Company at a purchase price of $0.80 per Warrant Share until November 27, 2027. The Company intends to use the proceeds of the Offering towards: (i) costs of completing the acquisition of the option (the “ Option ”) to acquire a 100% interest in the Alicahue Copper Project, located in the Valparaiso Region of Chile, (ii) exploration activities, Option payments, and property commitments on Alicahue, and (iii) working capital and general corporate purposes . For further information on the Option and the Alicahue Copper Project, see the Company's press release dated October 28, 2025.
|
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 16:54
1mo ago
|
Biotech Fund Reveals $15 Million MoonLake Exit After Stock's 90% Crash | stocknewsapi |
MLTX
|
|
|
A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
On November 14, MPM BioImpact reported in a U.S. Securities and Exchange Commission filing that it sold out its MoonLake Immunotherapeutics position, reducing exposure by $14.8 million in the third quarter. What happenedAccording to a U.S. Securities and Exchange Commission filing dated November 14, MPM BioImpact fully sold its stake in MoonLake Immunotherapeutics (MLTX +1.40%) during the third quarter. The fund disposed of 313,571 shares, eliminating a position that previously made up 2.6% of its assets under management. The move represented an estimated $14.8 million reduction based on quarterly average prices. What Else to KnowTop holdings after the filing: NASDAQ:MDGL: $46.1 million (7.5% of AUM)NASDAQ:CGEM: $45.4 million (7.4% of AUM)NASDAQ:RNA: $33.1 million (5.4% of AUM)NASDAQ:TRVI: $31.2 million (5.1% of AUM)NASDAQ:EWTX: $27.9 million (4.6% of AUM)As of Wednesday's market close, shares were priced at $13.80, down a staggering 74% from a year earlier and vastly underperforming the S&P 500, which is up 13% in the same period. Company OverviewMetricValuePrice (as of market close Wednesday)$13.80Market Capitalization$977.7 millionNet Income (TTM)($210.5 million)Company SnapshotMoonLake Immunotherapeutics is a Switzerland-based clinical-stage biotechnology company that is developing Sonelokimab, an investigational Nanobody therapy targeting inflammatory diseases such as hidradenitis suppurativa, psoriatic arthritis, and axial spondyloarthritis. The company operates a clinical-stage biopharmaceutical model, investing in research and development to advance its pipeline through clinical trials, with future revenue potential dependent on successful product commercialization and regulatory approval. Primary customers will include healthcare providers, hospitals, and specialty clinics treating patients with chronic inflammatory conditions, with a focus on unmet medical needs in immunology. Foolish TakeThis transaction comes at a wildly volatile time for MoonLake, whose stock collapsed nearly 90% in a single day in late September after mixed Phase 3 results surfaced for its investigational nanobody, sonelokimab—an event that triggered a class-action lawsuit and wiped out billions in market value. Whether this fund exited before or after that shock remains unclear from the filing, but a full divestiture during such an inflection point underscores how quickly conviction can shift when sentiment and data conflict. According to the latest SEC disclosure, the manager sold all 313,571 shares of MoonLake Immunotherapeutics in the third quarter—an estimated $14.8 million reversal that previously accounted for 2.6% of reportable assets. It also exited MBX Biosciences and Crinetics Pharmaceuticals during the same period, tightening exposure to high-volatility clinical names. MoonLake, meanwhile, continues to advance sonelokimab. In its Q3 release, which came earlier this month, the company reported $380.5 million in cash—projecting runway into the second half of 2027—and highlighted new Phase 2 data and a scheduled December 15 meeting with the FDA to assess the adequacy of its evidence package for sonelokimab. For long-term investors, the story serves as a warning of the risk in these types of investments, but for those holding on, the outlook now hinges less on the September shock and more on whether MoonLake can translate promising data into regulatory momentum. Glossary13F reportable assets: Assets a fund must disclose quarterly to the SEC, showing holdings in U.S. publicly traded securities. Assets under management (AUM): The total market value of investments managed by a fund or investment firm. Full exit: When an investor sells all shares of a particular holding, ending their position in that asset. Exposure: The amount of capital or percentage of a portfolio invested in a particular asset or sector. Stake: The ownership interest or number of shares held in a company by an investor or fund. Clinical-stage: Refers to a biotechnology or pharmaceutical company developing drugs that are currently being tested in human clinical trials. Nanobody: A small antibody fragment derived from camelids, used in developing targeted therapies for diseases. Pipeline: The portfolio of drug candidates a biopharmaceutical company is developing, typically at various stages of research and trials. Commercialization: The process of bringing a new product or therapy to market and generating sales. Regulatory approval: Official authorization from government agencies allowing a drug or therapy to be marketed and sold. Unmet medical needs: Health conditions for which current treatments are inadequate or unavailable. TTM: The 12-month period ending with the most recent quarterly report. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 16:55
1mo ago
|
Dream Industrial REIT Appoints Chief Operating Officer | stocknewsapi |
DREUF
|
|
|
-
TORONTO--(BUSINESS WIRE)--DREAM INDUSTRIAL REIT (TSX: DIR.UN) or (the “Trust”) and DREAM OFFICE REIT (TSX: D.UN) or (“Dream Office”) are pleased to announce the appointment of Mr. Gord Wadley as the Trust's Chief Operating Officer effective January 1, 2026. In his new role with the Trust, Mr. Wadley will be responsible for all aspects of portfolio operations including property management and leasing. Mr. Wadley is currently the Chief Operating Officer of Dream Office REIT. He joined the company in 2011 and has held progressively senior positions including Vice President, Leasing and Senior Vice President, Commercial Properties. Prior to joining Dream Office, Mr. Wadley worked in commercial brokerage for CB Richard Ellis providing commercial representation to corporate clients both domestic and international. Mr. Wadley earned a degree from Acadia University and earned his MBA in Real Estate Leadership from the University of Fredericton, New Brunswick. “We are excited to have Gord Wadley join the Dream Industrial team as Chief Operating Officer,” said Alexander Sannikov, President and Chief Executive Officer of Dream Industrial REIT. “Gord brings a proven track record of operational excellence, strategic leadership and effective execution over many years at Dream that will further strengthen our robust operating platform across our key markets. As we continue to grow our platform and portfolio, Gord’s experience and insight will be instrumental in driving efficiencies and delivering value to our shareholders, employees and customers.” "On behalf of Dream Office REIT, I want to express our deep gratitude to Gord for fifteen years of exceptional leadership and commitment,” said Michael Cooper, Chairman and Chief Executive Officer of Dream Office REIT. “Gord played an instrumental role in shaping our strategy, strengthening our operations, and building trusted relationships that have been central to our success. We are pleased to see Gord assume a great growth opportunity within the Dream Group so that he can continue taking on increasing contributions to the organization and provide seamless transition for Dream Office to the many talented leaders ready to take on more responsibility.” About Dream Industrial REIT Dream Industrial REIT is an owner, manager and operator of a global portfolio of well-located, diversified industrial properties. As at September 30, 2025, the REIT has an interest in and manages a portfolio which comprises 340 industrial assets (552 buildings) totalling approximately 73.2 million square feet of gross leasable area in key markets across Canada, Europe, and the U.S. The REIT’s objective is to deliver strong total returns to its unitholders through secure distributions as well as growth in net asset value and cash flow per unit underpinned by its high-quality portfolio and an investment grade balance sheet. Dream Industrial REIT is an unincorporated, open-ended real estate investment trust. For more information, please visit www.dreamindustrialreit.ca. About Dream Office REIT Dream Office REIT is an unincorporated, open-ended real estate investment trust. Dream Office REIT owns a carefully curated portfolio of office properties totalling approximately 4.8 million square feet, predominantly in well located, central business locations within downtown Toronto. For more information, please visit www.dreamofficereit.ca. More News From Dream Industrial REIT and Dream Office REIT Back to Newsroom |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 16:59
1mo ago
|
Gold (XAU/USD) Price Forecast: Weekly Bullish Higher Low – 20-Day Support Key | stocknewsapi |
AAAU
BAR
DBP
DGL
GLD
GLDM
IAU
OUNZ
SGOL
UGL
|
|
|
Upside Breakout Levels
An upside breakout of the consolidation triangle as it is currently configured is initially triggered above the top trendline but more reliable on a rise above the lower swing high at $4,245. That breakout level confirms a triangle breakout as well as generating a higher swing high and continuation of the bull trend begun from the October swing low. A rising ABCD pattern on the chart shows an initial 78.6% harmonic target for the pattern at $4,280, while price symmetry between the two rising measured moves completes at $4,356. This makes those two price levels the first upside targets on a breakout above the high for November at $4,245 (B). Near-Term Trigger However, an initial signal for a continuation of the bull trend towards the $4,245 high is on a sustained breakout above Wednesday’s high and the current high of the CD leg of the advance at $4,173. The breakout will need to prove itself once triggered, with a clear pick-up in bullish momentum. Weekly Bullish Context The weekly chart shows a bullish view, with a higher weekly high and higher low established following another successful test of support at the 20-day moving average. That is consistent with dynamic support near the longer-view 10-week average. A weekly close above last week’s high of $4,133 will confirm the weekly bull breakout and show buyers in control on that time frame. Subsequently, if gold stays above this week’s low of $4,040, the potential for the long-term bull trend to resume remains the most likely possibility for now. Outlook Tighter risk management can be achieved by the 20-day average support indicated at $4,075 currently and rising again after a slightly bearish decline. The more significant potential dynamic support line is at the 50-day average at $4,019. A decisive move above $4,173–$4,245 targets $4,280–$4,356; failure to clear the downtrend line risks a lower swing high and test of $4,075 – $4,040. For a look at all of today’s economic events, check out our economic calendar. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:00
1mo ago
|
Royal Road Minerals Announces Closing of Non-Brokered LIFE Financing | stocknewsapi |
RRDMF
|
|
|
November 27, 2025 5:00 PM EST | Source: Royal Road Minerals Limited
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Royal Road Minerals Limited. (TSXV: RYR) (OTCQB: RRDMF) (the "Company" or "Royal Road") is pleased to announce that, further to its press release of November 3, 2025, it has successfully closed its non-brokered private placement offering (the "Offering") through the issuance of 27,772,523 ordinary shares (each, a "Share") in the capital of the Company at a price of $0.18 per Share for gross proceeds of $5,000,000. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), the Shares were offered for sale to purchasers resident in Canada and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 as amended by CSA Coordinated Blanket Order 45-935 (the "LIFE Exemption"). Because the Offering was completed pursuant to the LIFE Exemption, the Shares issued pursuant to the Offering are not subject to a hold period pursuant to applicable Canadian securities laws. The Offering attracted solid interest from both existing and new investors. The Company further confirms that its largest shareholder, Rio2 Limited, maintains its approximately 15% equity stake in Royal Road following completion of the Offering. In connection with the closing of the Offering, the Company paid certain eligible persons cash commissions in the aggregate amount of $251,319.23 and issued an aggregate of 1,396,215 broker warrants (each, a "Broker Warrant"). Each Broker Warrant entitles the holder thereof to acquire one Share at a price of $0.18 per Share for a period of thirty-six (36) months from the closing of the Offering. The net proceeds from the Offering will be used to expand drilling programs across Royal Road's properties in Colombia and the Kingdom of Saudi Arabia, as more specifically detailed in the Company's offering document dated November 3, 2025 prepared and filed in accordance with the LIFE Exemption. The Offering constituted a related party transaction within the meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101") as insiders of the Company subscribed for an aggregate of 4,502,223 Shares. The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101, as the Company is not listed on a specified market and the fair market value of the participation in the Offering by insiders does not exceed 25% of the market capitalization of the Company in accordance with MI 61-101. The Company did not file a material change report in respect of the related party transaction at least 21 days before the closing of the of the Offering, which the Company deems reasonable in the circumstances in order to complete the Offering in an expeditious manner. The securities issued pursuant to the Offering have not been, and will not be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. About Royal Road Minerals: Royal Road Minerals is a mineral exploration and development company with its head office and technical-operations center located in Jersey, Channel Islands. The Company is listed on the TSX Venture Exchange under the ticker RYR, on the OTCQB under the ticker RRDMF and on the Frankfurt Stock Exchange under the ticker RLU. The Company's mission is to apply expert skills and innovative technologies to the process of discovering and developing copper and gold deposits of a scale large enough to benefit future generations and modern enough to ensure minimum impact on the environment and no net loss of biodiversity. The Company currently explores in the Kingdoms of Saudi Arabia, Morocco and in Colombia. More information can be found on the Company's website www.royalroadminerals.com. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary statement: This news release contains certain statements that constitute forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, "forward-looking statements") describing the Company's future plans and the expectations of its management that a stated result or condition will occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or developments in the Company's business or in the mineral resources industry, to differ materially from the anticipated results, performance, achievements or developments expressed or implied by such forward-looking statements. Forward-looking statements include all disclosure regarding possible events, conditions or results of operations that is based on assumptions about, among other things, future economic conditions and courses of action, and assumptions related to government approvals, and anticipated costs and expenditures. The words "plans", "prospective", "expect", "intend", "intends to" and similar expressions identify forward looking statements, which may also include, without limitation, any statement relating to future events, conditions or circumstances. Forward-looking statements of the Company contained in this news release, which may prove to be incorrect, include, but are not limited to the Company's exploration plans. The Company cautions you not to place undue reliance upon any such forward-looking statements, which speak only on the date they are made. There is no guarantee that the anticipated benefits of the Company's business plans or operations will be achieved. The risks and uncertainties that may affect forward-looking statements include, among others: economic market conditions, anticipated costs and expenditures, government approvals, and other risks detailed from time to time in the Company's filings with Canadian provincial securities regulators or other applicable regulatory authorities. Forward-looking statements included herein are based on the current plans, estimates, projections, beliefs and opinions of the Company management and the Company does not undertake any obligation to update forward-looking statements should assumptions related to these plans, estimates, projections, beliefs and opinions change. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276214 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:00
1mo ago
|
Denarius Metals Announces Details for the November 30, 2025 Interest Payments on Its Convertible Unsecured Debentures | stocknewsapi |
DNRSF
|
|
|
November 27, 2025 5:00 PM EST | Source: Denarius Metals Corp.
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or the "Company") announced today the details for the forthcoming monthly interest payments due on November 30, 2025 on its convertible unsecured debentures due October 19, 2029 (the "2023 Debentures") and May 30, 2030 (the "2024 Debentures"). The table below summarizes the details for the shares to be issued on December 1, 2025 to holders of the 2023 Debentures and the 2024 Debentures in settlement of the monthly interest due November 30, 2025: Principal Amount of Debentures (1) (CA$) Interest (CA$)Number of Shares to be Issued (2)Number of Shares per CA$1.00 of Principal 2023 Debentures 19,886,560198,866382,4320.0192312024 Debentures 14,272,314142,723274,4680.019231 Total34,158,874341,589656,900 (1) Issued and outstanding as of November 27, 2025. (2) Based on the closing price of the common shares on Cboe CA of CA$0.52 per share on November 14, 2025, the Monthly Measurement Date pursuant to the Third Supplemental Indentures for the 2023 Debentures and the 2024 Debentures. The issuance of the common shares in settlement of the interest payable on the debentures due November 30, 2025 is subject to the acceptance of Cboe Canada. Mr. Serafino Iacono (Executive Chairman), Mr. Federico Restrepo-Solano (Director and CEO), Mr. Michael Davies (Chief Financial Officer) and Ms. Amanda Fullerton (General Counsel and Secretary) will receive an aggregate of 168,226 common shares in settlement of the interest payable on their respective holdings of 2023 Debentures and 2024 Debentures. About Denarius Metals Denarius Metals is a Canadian junior company engaged in the acquisition, exploration, development and eventual operation of precious metals and polymetallic mining projects in high-grade districts in Colombia and Spain. Denarius Metals is listed on Cboe Canada where it trades under the symbol "DMET". The Company also trades on the OTCQX Market in the United States under the symbol "DNRSF". In Colombia, Denarius Metals commenced mining operations in the second quarter of 2025 at its 100%-owned Zancudo Project, a high-grade gold-silver deposit, which includes the historic producing Independencia mine, located in the Cauca Belt, about 30 km southwest of Medellin. In Spain, Denarius Metals has interests in three projects focused on in-demand critical minerals. The Company owns a 21% interest in Rio Narcea Recursos, S.L. and is the operator of its Aguablanca Project, which has been recognized by the EU as a Strategic Project. The Aguablanca Project comprises a turnkey 5,000 tonnes per day processing plant and the rights to exploit the historic producing Aguablanca nickel-copper mine, located in Monesterio, Extremadura. Denarius Metals also owns a 100% interest in the Lomero Project, a polymetallic deposit located on the Spanish side of the prolific copper rich Iberian Pyrite Belt, approximately 88 km southwest of the Aguablanca Project, and a 100% interest in the Toral Project, a high-grade zinc-lead-silver deposit located in the Leon Province, Northern Spain. Additional information on Denarius Metals can be found on its website at www.denariusmetals.com and by reviewing its profile on SEDAR+ at www.sedarplus.ca. Cautionary Statement on Forward-Looking Information This news release contains "forward-looking information", which may include, but is not limited to, statements with respect to anticipated business plans or strategies, including Cboe Canada final acceptance of the share issuance. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Denarius Metals to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in the Company's Annual Information Form dated March 31, 2025 which is available for view on SEDAR+ at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this press release and Denarius Metals disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or if management's estimates or opinions should change, or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276190 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:03
1mo ago
|
Crude Oil Price Forecast: $57.21 Bottom Holds – Bull Reversal Targets $60.98 | stocknewsapi |
BNO
DBO
GUSH
IEO
OIH
OIL
PXJ
UCO
USO
XOP
|
|
|
Reversal from Channel Support
The reversal has triggered following several days when support was recognized at the bottom trendline of a descending channel. Of note is the 88.6% Fibonacci retracement level at $56.16, which helped identify a trend low at $57.21 along with the lower channel line. That is a close match that was followed by an intraday rally and a closing price in the top half of the day’s range. More bullish price behavior. The continuation of that signal was seen with today’s bullish price action and a strong close for the session. Key Resistance Levels Ahead The top downtrend line subsequently becomes an initial upside target with the 20-day average at $59.68 also in sight. But given recent consolidation the 20-day line is not so useful as a decision level other than as a minor indication. The 50-day average at $60.63 marks a key area of dynamic resistance for the current downtrend. Along with the most recent lower swing high at $60.98, these mark the two key resistance levels that need to be broken before higher prices become more likely. Outlook If crude oil is going to have a chance of a second bull leg up from the October swing low of $56.41, it first needs to close above $60.98 and then above $61.43. A reclaim of the 50-day will have then occurred as well, further indicating that the bulls are getting more aggressive. Following a bullish reversal of the short-term declining channel, there is a chance that the momentum could spike in a similar fashion to what was seen following the first bottom in October. Symmetry in the two rising measured moves would be achieved at $63.83 (D). That presents both a potential initial upside target based on the pattern but also an area where resistance could turn price down. For a look at all of today’s economic events, check out our economic calendar. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:04
1mo ago
|
Surface Metals Inc. Announces Closing of First Tranche of Private Placement Financing | stocknewsapi |
SURMF
|
|
|
November 27, 2025 5:04 PM EST | Source: Surface Metals Inc.
Vancouver, British Columbia--(Newsfile Corp. - November 27, 2025) - Surface Metals Inc. (CSE: SUR) (OTCQB: SURMF) (the "Company", or "Surface Metals") announced today that the Company has closed a first tranche of its non-brokered private placement financing, previously announced on October 20, 2025. The Company issued 1,600,000 units (the "Units") at $0.20 CAD per Unit for aggregate gross proceeds of $320,000 CAD. Each Unit is comprised of one (1) common share and one-half of one (1) transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.40 for two (2) years from closing of the Offering. The Issuer intends to use the proceeds of the offering to fund technical work at its Nevada gold and lithium projects, as well as for general working capital purposes. Finder's fee of $10,500 and 52,500 finder's warrants were paid to arm's lengths parties in connection with the Offering (each finder's warrant exercisable on the same terms as the warrants forming part of the Units). All securities that are issued pursuant to the offering are subject to, among other things, a hold period of four months and one day in accordance with applicable Canadian securities laws. About Surface Metals Inc. Surface Metals Inc. (CSE: SUR) (OTCQB: SURMF) is a North American mineral exploration company focused on advancing a diversified portfolio of gold and lithium projects in Nevada, USA, and Manitoba, Canada. The Company's Cimarron Gold Project is located in Nye County, Nevada, in a historically productive gold district. It's Clayton Valley Lithium Brine Project hosts an inferred resource of approximately 302,900 tonnes LCE adjacent to Albemarle's Silver Peak Mine. Surface Metals also holds additional lithium assets in Fish Lake Valley, Nevada, and through a joint venture with Snow Lake Energy in southeastern Manitoba. Neither the CSE nor its regulations service providers accept responsibility for the adequacy or accuracy of this news release. This news release contains certain statements which may constitute forward-looking information within the meaning of applicable securities laws ("forward-looking statements"). These include statements regarding the amount of funds to be raised under the Offering, and the use of such funds. There is no guarantee the Offering will be completed on the terms outlined above, or at all. Use of funds is subject to the discretion of the Company's board of directors, and as such may be used for purposes other than as set out above. Any forward-looking statement speaks only as of the date it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276222 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:06
1mo ago
|
Mustang Energy Advances Option with Skyharbour at the 914W Uranium Project and Announces Other Corporate Updates | stocknewsapi |
MECPF
|
|
|
VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Energy Corp. (CSE: MEC, OTC:MECPF, FRA:92T) (the “Company” or “Mustang”) is pleased to announce that it has completed the second tranche of milestone payments to Skyharbour Resources Ltd. (“Skyharbour”) under the option agreement between Mustang and Skyharbour dated November 12, 2024 (the “Option Agreement”) regarding the 914W Uranium Project. Pursuant to the Option Agreement, Mustang paid Skyharbour $20,000 in cash, issued 1,098,901 common shares (each, a “Share”) in the capital of Mustang at a deemed price per Share of $0.091, and completed $100,000 in exploration expenditures on the 914W Uranium Project to satisfy the second tranche of milestone payments. The Shares are subject to a customary hold period expiring on the date that is four months and one day following the date of issuance. For more information regarding the Option Agreement and the next set of milestone payments, please refer to the Company's news release dated November 13, 2024 and December 6, 2024, as filed under the Company's profile on www.sedarplus.ca.
|
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:15
1mo ago
|
US Thanksgiving online sales expected to rise 6%, Salesforce data shows | stocknewsapi |
CRM
|
|
|
Online sales in the U.S. on the Thanksgiving holiday are expected to rise 6% compared with last year to reach $8.6 billion, data from Salesforce showed on Thursday, suggesting shoppers were lapping up steep discounts from retailers to splurge amid tariff-induced macroeconomic uncertainty.
|
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:21
1mo ago
|
ROSEN, A LEADING LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX | stocknewsapi |
TLX
|
|
|
November 27, 2025 5:21 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Telix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix's supply chain and partners; and (3) as a result, defendants' statements about Telix's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275967 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:22
1mo ago
|
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results | stocknewsapi |
CELC
|
|
|
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
New York City-based Apis Capital Advisors disclosed a new position in Celcuity Inc. (CELC +1.26%), acquiring 776,000 shares valued at $38,334,400 as of September 30, according to an SEC filing submitted on November 14, 2025. What HappenedAccording to a Securities and Exchange Commission (SEC) filing dated November 14, Apis Capital Advisors, LLC initiated a new position in Celcuity (CELC +1.26%), purchasing 776,000 shares during the third quarter. The stake was valued at $38.33 million as of September 30 and accounts for 8.5% of the fund’s $452.7 million in reportable U.S. equity assets. What Else to KnowTop holdings after the filing: NASDAQ:CELC: $38.3 million (8.5% of AUM)NASDAQ:TLN: $32.5 million (7.2% of AUM)NASDAQ:SIMO: $27.1 million (6% of AUM)NASDAQ:SSRM: $27.1 million (6% of AUM)NASDAQ:STX: $27 million (6% of AUM)As of Wednesday's market close, CELC shares were priced at $100.35, up a staggering 669% over the past year and vastly outperforming the S&P 500's 13% gain in the same period. Company OverviewMetricValueMarket capitalization$4.6 billionShare price (as of Wednesday)$100.35Revenue (TTM)$0Net income (TTM)($162.7 million)Company SnapshotCelcuity Inc. is a clinical-stage biotechnology firm specializing in precision oncology solutions, including its lead candidate Gedatolisib and the CELsignia diagnostic platform for personalized oncology treatment. The company leverages proprietary diagnostic and therapeutic platforms, and its strategy centers on identifying and targeting abnormal cellular signaling in cancer, aiming to improve patient outcomes through personalized medicine. Its competitive edge lies in integrating diagnostics with drug development, supported by strategic licensing agreements and a focused R&D pipeline. Celcuity primarily serves pharmaceutical partners, research institutions, and healthcare providers focused on advanced or metastatic breast and ovarian cancer. Foolish TakeA fresh stake in a fast-moving clinical-stage biotech signals conviction in a company still in the early innings of proving out its science—and Celcuity’s surge into all-time-high territory suggests that conviction is building quickly. With the stock up more than 650% in a year, investors are treating Celcuity as one of the year’s most promising precision oncology stories. According to the latest SEC filing, the fund acquired 776,000 Celcuity shares valued at $38.3 million, making it the manager’s largest reported position at 8.5% of AUM—that's while trimming its former top holding, GEO Group. Celcuity’s momentum is backed by rapid clinical and platform progress. The company is advancing gedatolisib in breast and ovarian cancer and continues to develop its CELsignia diagnostics to better target therapy to tumor-specific signaling. As CEO Brian Sullivan told Investor’s Business Daily, Celcuity aims to “solve a 20-year riddle” in cancer treatment by addressing the complexity of PAM-pathway signaling—an approach that has eluded drug developers. Following positive phase 3 results for gedatolisib, the company on November 17 submitted a new drug application for the therapy to the Food and Drug Administration. For long-term holders, the thesis now rests on whether Celcuity can turn scientific validation into regulatory and commercial milestones—an inflection point that often separates durable compounders from short-lived speculative runs. GlossaryAssets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm. 13F assets: U.S. equity securities reported by institutional investment managers in quarterly SEC Form 13F filings. Trailing twelve months (TTM): The 12-month period ending with the most recent quarterly report. Clinical-stage: Refers to a company developing drugs or therapies that are still undergoing human clinical trials and not yet approved for sale. Precision oncology: Cancer treatment approach tailored to individual genetic or molecular characteristics of a patient's tumor. Personalized medicine: Medical care designed to optimize treatment effectiveness for individual patients based on their unique characteristics. Diagnostic platform: A technology or system used to detect or analyze specific biological markers for disease diagnosis or treatment decisions. Therapeutic platform: A set of technologies or methods used to develop and deliver treatments for diseases. Licensing agreement: A legal contract allowing one party to use another's intellectual property, technology, or products for a fee or royalties. R&D pipeline: The portfolio of drugs, therapies, or products a company is researching and developing, often at various stages. Molecularly targeted therapies: Treatments designed to specifically target molecular pathways or abnormalities involved in disease progression, especially cancer. Outperforming: Achieving better returns or results compared to a benchmark or peer group, such as the S&P 500 index. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:23
1mo ago
|
Canadian National Railway Company (CNR:CA) Presents at Desjardins Toronto Conference Transcript | stocknewsapi |
CNI
CNR
|
|
|
Canadian National Railway Company (CNR:CA) Desjardins Toronto Conference November 24, 2025 8:00 AM EST
Company Participants Ghislain Houle - Executive VP & CFO Stacy Alderson - Assistant Vice-President of Investor Relations François Bélanger Conference Call Participants Benoit Poirier - Desjardins Securities Inc., Research Division Presentation Benoit Poirier Desjardins Securities Inc., Research Division Thank you very much, François, and good morning, everyone. So our first presenter is a cornerstone of the economy, those who've been a big supporter. They started with us 10 years ago. And I think Ghislain said that he was presenting 10 years ago with us. So he hasn't changed. Ghislain Houle Executive VP & CFO I think I did. I'm more gray. Benoit Poirier Desjardins Securities Inc., Research Division But thank you very much. So they just came out with the third quarter results. So the results were very well received. They took some action given the challenging freight environment. So today with us, Ghislain, Executive Vice President and CFO. We have Stacy Alderson, also EVP, Investor Relations. And François -- also François Bélanger, Senior Director of Sustainability. So this is our first time. So thank you very much for joining us this morning. First question, stronger-than-expected third quarter... Ghislain Houle Executive VP & CFO Let me make a few comments. We agreed on that. You're changing your mind, my friend. So first of all, thank you for having us [Foreign Language]. And yes Benoit, we're supporting you, supporting Desjardins. We've been a big partner with you guys for many, many years. So maybe just a few quick comments on the business, and then we can turn over to your questions, and you've got some good questions. So I'm going to try not to steal your thunder. When you look at the volumes and when I talk about Recommended For You |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:25
1mo ago
|
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR | stocknewsapi |
AVTR
|
|
|
November 27, 2025 5:25 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Avantor class action, go to https://rosenlegal.com/submit-form/?case_id=47303 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants misrepresented and/or failed to disclose that: (1) Avantor's competitive positioning was weaker than defendants had publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, defendants' representations about Avantor's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Avantor class action, go to https://rosenlegal.com/submit-form/?case_id=47303 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275979 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:26
1mo ago
|
Dream Impact Trust Announces Correction to Voting Results of Special Meeting of Unitholders | stocknewsapi |
DDHRF
|
|
|
-
TORONTO--(BUSINESS WIRE)--DREAM IMPACT TRUST (TSX: MPCT.UN) (“Dream Impact” or the “Trust”), announced today that, at its special meeting (the “Meeting”) of unitholders of the Trust (“Unitholders”) held earlier today, Unitholders approved the resolution (the “Amendments Resolution”) approving amendments to the terms of the Trust’s outstanding 5.50% convertible unsecured subordinated debentures due 2026 (the “Debentures”) to change the conversion price of such debentures from $31.02 per unit to $2.75 per unit and to make such other consequential amendments as are required to give effect to such change, as described in more detail in the Trust’s management information circular dated October 20, 2025 (the “Circular”). At the Meeting, the Amendments Resolution required approval by at least a simple majority of the votes cast by the Unitholders present in person or represented by proxy and entitled to vote at the Meeting. A total of 8,183,043 units of the Trust were represented in person or by proxy at the Meeting. The Amendments Resolution was approved by approximately 95.07% of the votes cast by the Unitholders present in person or represented by proxy and entitled to vote at the Meeting (rather than 44.43% as previously announced). Details of the voting results will be filed under the Trust’s profile at www.sedarplus.com and available on the Trust’s website at www.dreamimpacttrust.ca. The Trust will enter into an amended and restated trust indenture with respect to the Debentures in order to implement the amendments described in the Circular, including the change to the conversion price of the Debentures referred to above. The amendments are expected to be implemented in the fourth quarter of 2025, with the increase to the interest rate of the Debentures from 5.50% to 6.50% commencing for the period beginning on or about January 31, 2026. About Dream Impact Trust Dream Impact is an open-ended trust dedicated to impact investing. Dream Impact’s underlying portfolio is comprised of exceptional real estate assets reported under two operating segments: development and recurring income, that would not be otherwise available in a public and fully transparent vehicle, managed by an experienced team with a successful track record in these areas. The objectives of Dream Impact are to create positive and lasting impacts for our stakeholders through our three impact verticals: environmental sustainability and resilience, attainable and affordable housing, and inclusive communities. For more information, please visit: www.dreamimpacttrust.ca. More News From Dream Impact Trust Back to Newsroom |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:30
1mo ago
|
Abcourt Announces its Results for the First Quarter Ended September 30, 2025 and the Engagement of Red Cloud Securities to Provide Market-Making Services | stocknewsapi |
ABMBF
|
|
|
November 27, 2025 17:30 ET
| Source: Abcourt Mines Inc. ROUYN-NORANDA, Quebec, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the first quarter ended September 30, 2025. All monetary values in this press release are expressed in Canadian dollars, unless otherwise indicated. Financial statements and management discussion and analysis are available on SEDAR+. Summary of financial results (In dollars)Three months ended September 30 2025 2024 Revenues– – Costs of sales5,009,786 – Loss from mining operations(5,009,786) – Administration expenses1,416,858 775,757 Care and maintenance29,288 887,433 Exploration expenses250,068 501,160 Finance expenses967,143 136,415 Net loss and comprehensive loss(7,519,605) (1,839,901) Net loss per share, basic and diluted(0.01) (0.00) (In dollars)September 30, 2025June 30, 2025Cash594,357 2,578,587 Total assets31,811,592 21,408,153 Non-current liabilities28,029,185 14,175,891 Shareholders’ equity(5,488,044)(599,534)Working capital (non-IFRS measurement) *1,288,412 2,952,725 * Working capital is a non-IFRS measurement with no standardized meaning under IFRS. For further information, please see section "Non-IFRS Measure". During the quarter, Abcourt began development of mining operations at Sleeping Giant. Several expenses related to the development of drifts and rehabilitated already developed drifts to access the production stopes planned, maintenance of installations and equipment and hiring employees.Abcourt began to fill the mill’s circuit with gold.On surface, Abcourt built phase 1 of the sleep camp and kitchen during the quarter. They were commissioned on September 2nd. Abcourt also executed civil construction work at the tailing facility in preparation for the Winter and the preparation for the next lift planned in cell 2A for the Summer 2026. Non-IFRS Measure This press release presents working capital as a performance measure which is non-International Financial Reporting Standards (IFRS) performance measure. The Corporation believes that this measure provides investors with an improved ability to evaluate the performance of the Corporation. Non-IFRS measures do not have any standardized meaning prescribed under IFRS. Therefore, such measures may not be comparable to similar measures employed by other companies. This data may not be comparable to data presented by other companies. Non-GAAP financial performance measures should be considered together with other data prepared in accordance with IFRS. The Corporation determines working capital as follows: current assets less current liabilities. Engagement of Red Cloud Securities Inc to provide market-making services The Corporation has, subject to the approval of the TSX Venture Exchange (“TSXV”), engaged the services of Red Cloud Securities Inc. ("RCSI") to provide market-making services in accordance with TSXV policies. RCSI will trade shares of the Corporation on the TSXV with the objective of maintaining a reasonable market and improving the liquidity of the Corporation's common shares. Under the agreement, there are no performance factors contained in the agreement and RCSI will not receive shares or options as compensation. Mr. Chad Williams, a director of the Corporation, is a significant shareholder of the parent company of RCSI and, as a result, the Corporation is non-arm’s length to RCSI. Mr. Williams does not have control or influence over the day-to-day operations of RCSI and, in particular, he has removed himself from this matter and the delivery of these services. The terms of RCSI’s engagement (including fees payable under the agreement) were determined following customary negotiations between the Corporation and RCSI and are reasonable and consistent with market practice. As of the date hereof, RCSI beneficially owns or controls 14,000 common shares of the Corporation and 9,891,805 securities convertible into common shares. RCSI’s office is located at 120 Adelaide Street West, Suite 1400, Toronto, Ontario M5H 1T1. Abcourt Mines Inc. Abcourt Mines Inc. is a Canadian gold exploration company with properties strategically located in northwestern Quebec, Canada. Abcourt owns the 100% owned Sleeping Giant mine and mill and the Flordin property, where it focuses its development activities. For more information about Abcourt Mines Inc., please visit our website and view our filings under Abcourt's profile on www.sedarplus.ca FORWARD-LOOKING STATEMENTS Certain information contained in this news release may constitute "forward-looking information" within the meaning of Canadian securities legislation. Generally, forward-looking information can be identified by using forward-looking terminology, such as "plans", "aims", "expects", "projects", "intends", "anticipates", "estimates", "could", "should", "likely", or variations of such words and phrases or statements specifying that certain acts, events or results "may", "should", "will" or "be achieved" or other similar expressions. Forward-looking statements are based on Abcourt's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause Abcourt's actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements or information. Forward-looking statements are subject to business, economic and uncertainties and other factors that could cause actual results to differ materially from these forward-looking statements, including the relevant assumptions and risk factors set forth in Abcourt's public filings, which are available on SEDAR at www.sedarplus.ca. There can be no assurance that these statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Although Abcourt believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on such statements. Except as required by applicable securities laws, Abcourt disclaims any intention or obligation to update or revise any such forward-looking statements or information, whether as a result of new information, future events or otherwise. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:34
1mo ago
|
Simply Solventless Announces Q3 2025 Financial and Operating Results, Commercial Improvements, and 91 New Product Listings Across Canada | stocknewsapi |
SSLCF
|
|
|
November 27, 2025 5:34 PM EST | Source: Simply Solventless Concentrates Ltd.
Calgary, Alberta--(Newsfile Corp. - November 27, 2025) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or "the Company") is pleased to announce its financial and operating results for the three and nine months ended September 30, 2025, including fiscal year to date ("YTD") revenue of $34.5 million and Adjusted EBITDA of $7.5 million, significant commercial team and process improvements, and the receipt of 91 new product listings across Canada either directly or through third parties. The information set out in this press release should be read in conjunction with SSC's condensed interim consolidated financial statements as at and for the three and nine months ended September 30, 2025 ("Financial Statements") and the related management's discussion and analysis, which are available for review on SSC's SEDAR+ profile at www.sedarplus.ca. Adjusted EBITDA is a non-IFRS measure. See discussion in the Non-IFRS Financial Measures advisories section of this press release below. Jeff Swainson, President & CEO of SSC, stated: "Revenue for the nine months ended September 30, was up 199% from $11.5 million in the comparable period in 2024 to $34.5 million in 2025 ($46.0 million annualized). Despite demonstrating strong year over year revenue growth, which can come at the expense of profitability, our lean cost structure allows for strong returns, with 2025 YTD Adjusted EBITDA of $7.5 million ($10.0 million annualized). Moving forward we are keenly focused on driving revenue growth, spearheaded by 91 total new product listings across Canada (including 44 into two new provinces that are expected to start cash flowing in early Q1 2026), and by advancing the Humble retrofit, which we view as a very cash flow accretive investment opportunity." Fiscal YTD 2025 Financial Highlights INCOME STATEMENT FIGURESFor the nine months endedSeptember 30, 2025September 30, 2024YoY % INCREASEGross Revenue$34.5M$11.5M199%Gross Revenue/Share$0.309$0.20451%Net Revenue$27.2M$7.2M280%Net Revenue/Share$0.244$0.12792%Gross Profit$13.0M$(0.5)M2931%Gross Profit/Share$0.116$(0.008)1535%EBITDA(1)$14.5M$(2.9)M599%EBITDA/Share$0.130$(0.051)353%Adjusted EBITDA(1)$7.5M$(2.7)M379%Adjusted EBITDA/Share(2)$0.067$(0.048)242%Net Income$11.5M$(3.1)M470%Net Income/Share(2)$0.103$(0.055)287%Normalized Net Income (NNI)(1)$2.6M$(3.3)M178%NNI/Share(2)$0.023$(0.059)139%Cash from (used in) Operations Prior to Changes in Working Capital$5.6M$(2.9)M290%Cash from (used in) Operations After Changes in Working Capital$(1.7)M$(3.7)M(53%)Gross Margin %47.7%(6.4)%54.1%(1) Non-IFRS financial measure. See discussion in the Non-IFRS Financial Measures advisories section below. (2) Non-IFRS ratio, see discussion in the Non-IFRS Financial Measures advisories section below. Based on 111,532,488 weighted average common shares of SSC for the nine months ended September 30, 2025 and 56,524,569 weighted average common shares of SSC for the nine months ended September 30, 2024, as applicable. During the nine months ended September 30, 2025, SSC generated $34.5 million in gross revenue (2024 - $11.5 million), an increase of 199%. The increase in gross revenue was due primarily to the completion of the Lamplighter, CannMart, ANC and Humble acquisitions, in addition to the growth of SSC's Status brand, neutral sales of SSC's Astrolab and Zest brands, and reductions in sales in SSC's Roilty, Frootyhooty, and Lamplighter brands. The reduction in sales of these particular brands is being addressed commercially as discussed in the "Commercial Improvements" section below. Q3 2025 Financial Highlights INCOME STATEMENT FIGURESFor the three months ended,September 30, 2025September 30, 2024YoY % INCREASEGross Revenue$9.0M$6.3M43%Gross Revenue/Share$0.078$0.092(15%)Net Revenue$6.3M$4.1M56%Net Revenue/Share$0.055$0.059(7%)Gross Margin$2.9M$1.4M102%Gross Margin/Share$0.025$0.02120%EBITDA(1)$0.8M$(0.0)M4084%EBITDA/Share(2)$0.007$(0.000)2476Adjusted EBITDA(1)$1.1M$0.5M118%Adjusted EBITDA/Share(2)$0.009$0.00730%Net Income$(0.3)M$(0.1)M(197%)Net Income/Share(2)$(0.003)$(0.001)(77%)Normalized Net Income (NNI)(1)$(1.0)M$0.1M(942)%NNI/Share(2)$(0.008)$0.002(602)%Cash from Operations Prior to Changes in Working Capital$1.3M$0.2M405%Cash from (used in) Operations After Changes in Working Capital$0.1M$(3.4)M103%(1) Non-IFRS financial measure. See discussion in the Non-IFRS Financial Measures advisories section below. (2) Non-IFRS ratio, see discussion in the Non-IFRS Financial Measures advisories section below. Based on 115,502,799 weighted average common shares of SSC for the three months ended September 30, 2025 and 68,872,421 weighted average common shares of SSC for the three months ended September 30, 2024, as applicable. During the three months ended September 30, 2025, SSC generated $9.0 million in gross revenue (2024 - $6.3 million), an increase of 43%. The increase in gross revenue was due primarily to the completion of the Lamplighter, CannMart, ANC and Humble acquisitions, in addition to the growth of SSC's Status brand, neutral sales of SSC's Astrolab and Zest brands, and reductions in sales in SSC's Roilty, Frootyhooty, and Lamplighter brands. The reduction in sales of these particular brands is being addressed commercially as discussed in the "Commercial Improvements" section below. During the three months ended September 30, 2025, SSC generated $9.0 million in gross revenue (June 30, 2025 - $13.0 million), a decrease of 31% from the three months ended June 30, 2025. The reduction is primarily attributable to large sales to third party partners during the three months ended June 30, 2025 whereas the three months ended September 30, 2025 did not have such sales. These sales relate to these partners licensing and selling SSC's brands into two new provinces. Related to this product, the third parties received 41 new product listings of SSC's brands into one of these new provinces and three new product listings into the second new province. Refer to the "Commercial Improvements" section below for more information. The cash flows related to these new markets being entered into are expected to commence in late Q4 2025. SSC expects periodic replenishment orders from the third parties to begin in late Q4 2025 or early Q1 2026. SSC is encouraged by the positive impact to long-term sales that could result from entering these new markets. BALANCE SHEET FIGURESAs atSeptember 30, 2025December 31, 2024% INCREASETotal Assets$60.3M$38.6M57%Net Assets$31.9M$15.5M106%Working Capital(1)$19.8M$1.6M1,148%Current Ratio(1)2.531.08143%Inventory Turnover(1)1.32x0.78x45%(1) Non-IFRS financial measure. See discussion in the Non-IFRS Financial Measures advisories section below. YTD Q3 2025 Corporate Highlights: Appointment of Ananth Krishnan as Chief Financial Officer: On August 25, 2025 SSC appointed Ananth Krishnan to the position of Chief Financial Officer. Ananth brings over twenty years of experience in investment banking, investment management, financial management, investor relations, strategy, corporate development, commercial negotiations, and cannabis operations.Appointment of Emily Riehl as Vice President, Sales: On September 3, 2025, SSC appointed Emily Riehl to the position of Vice President, Sales. Emily is a high-achieving sales executive with over seven years of experience in the Canadian cannabis industry and a track record of building relationships with key retail accounts, provincial wholesale organizations, and budtenders. National Sales Force: SSC expanded its national team of key account and regional sales representatives from two to seven and believes that this sales force can increase the sales velocity of all SSC brands.Upcoming Appointment of Vice President, Marketing: SSC has agreed to employment terms with an experienced marketing professional and is expected to announce their appointment as Vice President, Marketing in the coming months. Sluggers Hit Deal: SSC reached an agreement with Natura Life + Science, a California cannabis company, to launch Sluggers Hit, the legendary northern California cannabis brand, in Canada. SSC has exclusivity on distribution of the Sluggers brand in Canada. Promissory Note Repayment & Amendment: On July 17, 2025 SSC closed the repayment of $3.4 million of promissory notes ("Notes") through the issuance of 6,875,000 common shares of SSC at $0.50 per common share (the "Equity Issuance"). For more information regarding the Equity Issuance and Notes, including important disclaimers please see the news release dated June 3, 2025. Commercial Improvements Simply Solventless is entering a high momentum commercial phase in its CPG channel. In addition to the significant team improvements outlined in the "Q3 Corporate Highlights" section above, we are executing a full refresh of our brand identities and product roadmap to strengthen our competitiveness, prioritize proven winning categories, and accelerate innovation across our portfolio. SSC's renewed commercial discipline is already generating results. In November 2025 alone, we achieved our strongest listings month to date with 91 new provincial listings, either direct or through partners, across multiple brands in Alberta, Ontario, Newfoundland (a new market), and British Columbia (a new market). See below for a summary of the 91 listings received: Frootyhooty: 25 total listings.Backcountry Organics: 8 total listings. Status: 11 total listings.Astrolab: 25 total listings. Roilty: 5 total listings. Lamplighter: 11 total listings. Sluggers: 3 total listings.Zest: 3 total listings. These listings are comprised of the following product types: 40 infused preroll listings.18 all in one vape listings.14 510 vape listings.13 concentrates listings. 6 edibles listings.As noted above, third parties received 44 new product listings into two new provinces for the sale of SSC's CPG products. Many of these listings are expected to launch imminently and through Q1 2026 with cash flows associated with these listings to begin shortly thereafter. SSC expects periodic replenishment orders from the third parties to begin in early 2026. SSC is encouraged by the positive impact to long-term sales that could result from entering these new markets. These wins reflect the early impact of our new team and revitalized go-to-market strategy, and position SSC for improved sell-through, greater retail visibility, and meaningful growth opportunities for the remainder of 2025 and in 2026. Board of Directors & Management Changes Steve Bjornson is stepping down from SSC's board of directors as part of his retirement. Steve was instrumental in SSC completing the reverse takeover of Dash Capital Corp. in December 2023, and we thank him for his significant contributions to SSC. A strong candidate to replace Steve Bjornson has been identified and SSC expects to announce the appointment of this individual as an independent director in the near future. SSC also announces that Jeff Lawrence, SSC's former Chief Commercial Officer, is no longer with the Company. SSC thanks Jeff for his many contributions to SSC over the last two years. Olen Vanderleeden, a member of SSC's board of directors, is currently assisting SSC's commercial team until a permanent appointment has been made. Olen was previously Chief Commercial Officer at Greentone Enterprises Inc. and prior thereto was Chief Commercial Officer at Zenabis Global Inc. The financial information in this press release has been reviewed and approved by the board of directors of SSC. About Simply Solventless Concentrates Ltd. SSC is a public company incorporated under the Business Corporations Act (Alberta). SSC's mission is to provide pure, potent, terpene-rich ready to consume cannabis products to discerning cannabis consumers. For more information regarding SSC, please see www.simplysolventless.ca. Simply Solventless Concentrates Ltd. Jeff Swainson, President and CEO Phone: 403-796-3640 Email: [email protected] Notice on Forward-Looking Information This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends", "expects", "projected" and similar expressions which are intended to identify forward-looking statements. More particularly and without limitation, this press release contains forward-looking statements concerning full year 2025 financial results, plans related to the Humble retrofit, new product listings with provincial wholesalers, timing and successful launch of any new products in market, associated cash flow generation from new product launches, and CPG and B2B revenue growth. SSC cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, assumptions and expectations, many of which are beyond the control of SSC, including expectations and assumptions concerning SSC, the ability to realize expected revenue and cost synergies of any acquisitions on the timelines expected, the risk that the business of any acquired entity will not be integrated successfully, the ability to maintain relationships with customers, employees and suppliers, the timing and market acceptance of products, competition in SSC's markets, SSC's reliance on customers, fluctuations in interest rates, SSC's ability to maintain good relations with its customers, employees and other stakeholders, changes in law or regulations, SSC's ability to protect its intellectual property, as well as other risks and uncertainties, including those described in SSC's filings available on SEDAR+ at www.sedarplus.ca. The reader is cautioned that assumptions used in the preparation of any forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of SSC. The reader is cautioned not to place undue reliance on any forward-looking statements. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release, and SSC does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by securities law. Future Oriented Financial Information This press release contains future-oriented financial information and financial outlook information (collectively, "FOFI") about revenue and adjusted EBITDA, which are subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraphs. FOFI contained in this document was approved by management as of the date of this document and was provided for the purpose of providing further information about SSC's future business operations. SSC and its management believe that FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments, and represent, to the best of management's knowledge and opinion, SSC's expected course of action. However, because this information is highly subjective, it should not be relied on as necessarily indicative of future results. SSC disclaims any intention or obligation to update or revise any FOFI contained in this document, whether as a result of new information, future events or otherwise, unless required pursuant to applicable law. Readers are cautioned that the FOFI contained in this document should not be used for purposes other than for which it is disclosed herein. Differences in the timing of capital expenditures or revenues and variances in production estimates can have a significant impact on the key performance measures included in SSC's guidance. SSC's actual results may differ materially from these estimates. Non-IFRS Financial Measures This press release contains certain financial performance measures and ratios that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other cannabis companies. For an explanation of these measures to related comparable financial information presented in the Financial Statements prepared in accordance with IFRS, refer to the discussion below. The Company believes that these Non-GAAP Measures are useful indicators of operating performance and are specifically used by management to assess the financial and operational performance of the Company. These Non-GAAP Measures include, but are not limited to current ratio, inventory turnover, working capital, EBITDA, adjusted EBITDA, and normalized net income. The definitions below should be read in conjunction with the "Cautionary Statement Regarding Non-GAAP Performance Measures" section of the Company's MD&A dated November 27, 2025, which includes discussion of the purpose and composition of the specified financial measures and detailed reconciliations to the most directly comparable IFRS financial measures. Current ratio is calculated by dividing current assets by current liabilities and is meant to indicate whether a company is capable of servicing its current liabilities. Inventory turnover is calculated by dividing cost of goods sold by inventory, and is meant to indicate how efficient a company is at turning inventory into cash. Working capital is an indicative measure of the Company's ability to service its short-term financial obligations with short-term assets. Management believes this measure provides useful information about the Company's current short-term liquidity. The numbers that are input into this calculation can be found in the statement of financial position in the Company's Financial Statements. EBITDA is calculated as income before interest and finance costs, taxes, depreciation and amortization expenses. EBITDA is considered as a useful measure by management of SSC to understand the profitability of SSC excluding the effects of capital structure, taxation and depreciation, but may not be appropriate for other purposes. EBITDA is considered a useful measure by management to understand profitability excluding the effects of capital structure, taxation and depreciation, but may not be appropriate for other purposes. EBITDA per share is used by the Company as a key performance indicator to evaluate the performance of SSC on a per share basis. The basic and/or diluted weighted average common shares outstanding used in the calculation of EBITDA per share is calculated using the same methodology as net income per share. Adjusted EBITDA is not defined under IFRS and therefore should not be considered an alternative to, or more meaningful than net income (loss) and comprehensive income (loss). Adjusted EBITDA is calculated as net income before interest and finance costs, taxes, depreciation and amortization expenses, share based compensation, gain settlement or disposal or bargain purchase gains, non-recurring restructuring costs and acquisition costs, foreign exchange gains and losses and government rebates, and other gains or costs that are expected to be non-recurring. Adjusted EBITDA is considered a useful measure by management to understand profitability excluding the effects of capital structure, taxation and depreciation, and non-recurring items, but may not be appropriate for other purposes. Adjusted EBITDA per share is used by the Company as a key performance indicator to evaluate the performance of SSC on a per share basis. The basic and/or diluted weighted average common shares outstanding used in the calculation of Adjusted EBITDA per share is calculated using the same methodology as net income per share. NNI is considered as a useful measure by management of SSC to understand the profitability of SSC excluding the effects of certain non-operating items. NNI is calculated as net income less gain settlement or disposal or bargain purchase gains, non-recurring restructuring costs and acquisition costs, foreign exchange gains and losses and government rebates, income tax recovery, and other gains or costs that are expected to be non-recurring. NNI per share is used by the Company as a key performance indicator to evaluate the performance of SSC on a per share basis. The basic and/or diluted weighted average common shares outstanding used in the calculation of NNI per share is calculated using the same methodology as net income per share. The following table reconciles current assets and current liabilities to Working Capital: As at,Sept 30, 2025Dec 31, 2024Cash$ 899,509$ 1,885,074Accounts receivable7,271,9143,934,569Biological assets1,011,778-Inventory22,174,62616,096,187Prepaids and deposits1,423,9561,385,115Accounts payable(4,415,431)(4,561,742)Deferred revenue-(228,009)Taxes and excise duties payable(4,046,460)(7,380,713)Short term loan(852,027)(653,533)Current portion of promissory note(1,750,442)(7,426,404)Vendor take back (400,000)(950,000)Current portion of lease liability(1,492,858)(474,412)Working capital$ 19,824,565$ 1,626,132The following table reconciles net income (loss) to EBITDA and Adjusted EBITDA: Three months endedNine months ended September 30, 2025June 30, 2025September 30, 2024September 30, 2025September 30, 2024Net and comprehensive income (loss)(297,281)3,398,547(100,061)11,509,274(3,112,027) Non-operating items Depreciation and amortization539,248289,64727,4091,415,98653,877Finance costs996,207613,16153,6542,156,260-Income tax recovery(122,269)--(219,483)154,423Deferred income tax recovery(358,944)--(358,944)-EBITDA756,9614,301,355(18,998)14,503,093(2,903,727) Non-operating items Restructuring costs145,050-225,348696,225225,348Acquisition costs---372,316-Foreign exchange loss13,8725,6763,85534,7233,979Impairment of intangible assets-63,970-63,970-Bargain purchase acquisition price538,299(560,288)-(7,747,902)-Gain on settlement(731,281)(833,750)(15,212)(1,565,031)(446,883)Share compensation expense332,247263,924288,8971,148,408434,554Adjusted EBITDA1,055,1483,240,887483,8907,505,802(2,686,729)Weighted Average Number of Shares115,502,799110,843,07768,872,421111,532,48856,524,569EBITDA per share0.0070.039(0.000)0.130(0.051)Adjusted EBITDA per Share0.0090.02920.0070.067(0.048)The following table reconciles net income (loss) to Normalized Net Income: Three months endedNine months ended September 30, 2025June 30, 2025September 30, 2024September 30, 2025September 30, 2024Net and comprehensive income(297,281)3,398,547(100,061)11,509,274(3,112,027) Non-operating items Restructuring costs145,050-225,348696,225225,348Acquisition costs---372,316-Foreign exchange loss13,8725,6763,85534,7233,979Impairment of intangible assets-63,970-63,970-Gain on settlement538,299(833,750)-(7,747,902)-Bargain purchase acquisition price(731,281)(560,288)(15,212)(1,565,031)(446,883)Gain on sale of asset(146,568)(47,837)-(194,405)-Income tax recovery(122,269)--(219,483)-Deferred income tax recovery(358,944)--(358,944)-Normalized Net Income(959,122)2,026,318113,9302,590,743(3,329,583)Weighted Average Number of Shares115,502,799110,843,07768,872,421111,532,48856,524,569Normalized Net Income per Share(0.008)0.0180.0020.023(0.059)This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Not for distribution to U.S. news wire services or for dissemination in the United States. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276223 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:49
1mo ago
|
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW | stocknewsapi |
PRMB
PRMW
|
|
|
November 27, 2025 5:49 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Primo Brands class action, go to https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, Primo Brands formed following the November 8, 2024 merger between Primo Water and BlueTriton Brands, is a branded beverage company that offers beverage products across a variety of formats, channels, and price points. According to the lawsuit, throughout the Class Period, defendants misrepresented and failed to disclose key facts about the merger between Primo Water and BlueTriton Brands, including facts regarding the progress of the merger integration. Defendants issued a series of materially false and misleading statements that led investors to believe the merger would accelerate growth, generate transformative operational efficiencies, achieve meaningful synergies, and deliver strong financial results, and that the merger integration was proceeding "flawlessly." When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Primo Brands class action, go to https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276077 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:50
1mo ago
|
Keysight Technologies' Surge: The Market Wakes Up to This AI Play | stocknewsapi |
KEYS
|
|
|
A nearly 10% surge in Keysight Technologies' NYSE: KEYS stock has turned heads on Wall Street, and for good reason. The sharp upward move followed a fiscal Q4 2025 earnings report that beat expectations.
|
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:53
1mo ago
|
Titan Logix Corp. Reports Fiscal 2025 Financial Results | stocknewsapi |
TPCFF
|
|
|
November 27, 2025 5:53 PM EST | Source: Titan Logix Corp.
(In $000's of Canadian dollars except for shares and per share amounts) Edmonton, Alberta--(Newsfile Corp. - November 27, 2025) - Titan Logix Corp., (TSXV: TLA) ("Titan" or the "Company"), a technology company specializing in mobile liquid measurement solutions, announces its interim results for the three- and twelve-month periods ended August 31, 2025. "We are excited about the commercial launch of our new product line in the refined petroleum market" says Nick Forbes, CEO at Titan. "Titan's new product line delivers the same reliability our customers expect in a new, innovative package". The company celebrated the launch of a new product line for the refined petroleum market at the end of the fiscal year. This milestone achievement will help diversify Titan's business into several new, liquid verticals outside of crude oil. The company has been focused on validating our new product line in the refined petroleum market by conducting pilot trials directly with fleet operators. The commercial launch of our new product line will enable sales through Dealer & OEM channels, leveraging their expertise and sales footprint across North America. Titan is a well-known brand with a strong reputation for accurate tank level measurement and reliable overfill protection, and we will focus our sales, marketing, and training efforts on these channel opportunities in the first half of the new fiscal year. In the first quarter of fiscal 2025, the company launched its first suite of connected apps, Titan Install and Titan Portal, as part of our technology modernization strategy. The launch has been a major success for the company, reducing the installation complexity for dealers and OEMs, and increasing the quality and reliability of our products. We expect that all products sold by the middle of fiscal 2026 will be installed using our connected apps. With the launch of Titan's connected apps and the new product line for the refined petroleum market, the company expects to shift focus from R&D investments to market penetration and adoption during the course of the new fiscal year. With the launch of our connected products, the company is also exploring opportunities for growth through integration, partnerships, and other channels to market. FISCAL 2025 HIGHLIGHTS Revenues for fiscal 2025 decreased slightly by $103 or 2% to $6,754 compared to $6,857 in fiscal 2024. Gross Profit decreased by $359 to $3,104 or 46% of revenue in fiscal 2025 compared to $3,463 or 51% in fiscal 2024, driven largely by isolated expenses the Company incurred to resolve a product quality issue as well as some erroneously charged tariff expenses. The performance of the core business declined moderately in fiscal 2025 with reported Operating EBITDA(1) of $929 compared to $1,148 in fiscal 2024. Product research and development expenses(1) increased by $273 to $1,388 in fiscal 2025 compared to $1,115 in fiscal 2024. The expenses incurred support the Company's diversification and growth into new markets. The Company's net earnings decreased by $982 to a net loss of $436 in fiscal 2025 compared to net income of $546 in fiscal 2024 with decreased operating results driven by reduced gross profit and increased product research and development expenses in fiscal 2025. In addition, net earnings in fiscal 2024 were impacted significantly by the recognition of previously unrecognized deferred tax assets of $724. The Company reported basic and diluted loss per share of $0.02 per share in fiscal 2025 compared to earnings per share of $0.02 in fiscal 2024. The Company implemented a Normal Course Issuer Bid ("NCIB") in April of 2025 to re-purchase and cancel up to 1,759,649 of the Company's outstanding common shares, representing approximately 10% of the public float of issued and outstanding common shares. As at August 31, 2025, the Company repurchased and cancelled 970,000 common shares at an average price of $0.76 per share plus transactions costs representing approximately 55% of the total amount eligible for repurchase. Financial Highlights Summary Three months endedTwelve Months Ended20252024Increase (Decrease)20252024Increase (Decrease)$$$%$$$%Revenue1,6091,666(58)(3)6,7546,857(103)(2)Cost of sales(1,139)(810)(330)(41)(3,650)(3,394)(256)8Gross profit469857(388)(45)3,1043,463(359)(10)Gross margin (%)29%51% (22)46%51% (5)Operating EBITDA (1)(39)256(295)1159291,148(219)(19)Product research and development expenses (1)(388)(317)(71)(22)(1,388)(1,115)(273)24Adjusted EBITDA (1)(427)(61)(366)(603)(459)33(492)(1,514)Net earnings (loss)(211)924(1,135)123(436)546(982)(180)EPS - Basic and Diluted(0.01)0.03(0.04) (0.02)0.02(0.03) Financial PositionAs at August 31, 2025As at August 31, 2024Working capital $ 14,395 $ 14,139Total assets $ 17,893 $ 19,022Long-term liabilities $ 457 $ 600Total equity $ 16,410 $ 17,502 (1) See non-IFRS measures below. The Company's audited consolidated financial statements and the management's discussion and analysis ("MD&A") which includes the Company's Business Outlook, for the three- and twelve-month periods ended August 31, 2025, are available on SEDAR+ at www.sedarplus.ca and the Company's website, www.titanlogix.com. NON-IFRS MEASURES The Company uses certain measures in this MD&A that do not have a standardized meaning as prescribed by IFRS (International Financial Reporting Standards) and thus are prohibited from being disclosed in the consolidated financial statements. These measures, which are derived from information reported in the Company's consolidated financial statements, may not be consistent with similar measures presented and disclosed by other reporting issuers. However, management believes that this information provides increased insight into the Company's strategic plan to address the broader mobile liquid markets. Readers are cautioned that these non-IFRS measures should not be construed as alternatives to other measures of financial performance calculated in accordance with IFRS. The table below provides a reconciliation of the Company's EBITDA and Operating EBITDA to the Operating income (loss) before other items per the interim consolidated financial statements for the periods presented: Fiscal Period EndedQ4 2025Q4 20242025F2024FOperating income (loss) before other items(535)(181)(952)(425)Add back: Depreciation and amortization 10196390380Add back: Non-cash stock-based compensation 72410378Adjusted EBITDA(427)(61)(459)33Add back: Product research and development expenses (1)3883171,3881,115Operating EBITDA (39)2569291,148The table below, removes the recurring engineering expenses from the total to isolate the product research and development expenses excluded in Management's calculation of Operating EBITDA: Fiscal Period EndedQ4 2025Q4 20242025F2024FEngineering, product research and development expenses(406)(366)(1,494)(1,314)Add back: Recurring engineering expenses1849106199Product research and development expenses(388)(317)(1,388)(1,115) A detailed definition of these non-IFRS measures can be reviewed in the Company's MD&A About Titan Logix Corp.: For over 25 years, Titan Logix Corp. has designed and manufactured mobile liquid measurement solutions to help businesses reduce risk and maximize efficiencies in bulk liquids transportation. Titan's TD Series of tank level monitors are a market leader in mobile fluid measurement, and are known for their high level of accuracy, rugged design, and solid-state reliability. Our solutions are designed for hazardous and non-hazardous applications, and we serve customers in a wide range of applications including petroleum, environmental solutions, chemical, and agriculture. Founded in 1979, Titan Logix Corp. is a public company listed on the TSX Venture Exchange and its shares trade under the symbol TLA. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Information in this press release that is not current or historical factual information may constitute forward looking information within the meaning of securities laws. Implicit in this information are assumptions regarding our future operational results. These assumptions, although considered reasonable by the company at the time of preparation, may prove to be incorrect. Readers are cautioned that the actual performance of the company is subject to many risks and uncertainties and could differ materially from what is expected as set out above. For more exhaustive information on these risks and uncertainties you should refer to our Management Discussion and Analysis in respect of the year ended August 31, 2023, which is available at www.sedarplus.ca. In addition, the occurrence of pandemics, such as the outbreak of the novel coronavirus COVID-19 in any of the areas in which the Company, its customers or its suppliers operate could cause interruptions in the Company's operations. In addition, pandemics, natural disasters, or other unanticipated events could negatively impact the demand for, and price of, oil and natural gas which in turn could have a material adverse effect on the Company's business, financial condition, results of operations and cash flows. The forward-looking information contained in this press release is based on our current estimates, expectations, and projections, which we believe are reasonable as of the current date. You should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While we may elect to, we are under no obligation and do not undertake to update this information at any time, whether a result of new information, future events or otherwise, except as required by applicable securities law TSX Venture, TLA To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276228 |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:53
1mo ago
|
boohoo group plc (BHOOY) Q2 2026 Earnings Call Prepared Remarks Transcript | stocknewsapi |
BHHOF
BHOOY
|
|
|
Dan Finley
CEO & Director Good morning, and welcome to the Debenhams Group Half Year Results for the 6 months ended 31st of August 2025. My name is Dan Finley, and I'm the Group CEO. And I'm joined this morning by Phil Ellis, our Group CFO. Our turnaround continues at pace. I'm pleased with the progress that we're making, but recognize that there is still much to do. Our new business model is rolling out. Stock-light, our stock is down to GBP 68 million, minus 35% on the same period last year. Capital-light, our CapEx is now GBP 7.5 million, down 50% on the same period last year and increasingly margin rich. Our adjusted EBITDA margin, 6.7%, up 180 basis points on the same period last year. Our financial performance is improving. Adjusted EBITDA is up GBP 20 million in the period, plus 5% on last year. Our net debt is down GBP 111 million, down 22%. And our loss before tax is down, a loss of GBP 3 million, down 97% on the same period last year. And our strategic transformation is progressing. We are creating the right operating model. Our fixed cost base has been reduced by GBP 160 million. We are supercharging Debenhams with 20% GMV growth in the period. And we are pivoting to fashion-led marketplaces with marketplace now representing 32% of our GMV. Debenhams.com is Britain's online department store. We are supercharging Debenhams. GMV has grown at 20%. EBITDA has grown at 50%, and we're generating an EBITDA margin of circa 15%. We have a highly attractive business model. Stock-light. We don't take the stock risk. Capital-light, margin-rich and highly cash generative. We have significant take |
|||||
|
2025-11-27 23:00
1mo ago
|
2025-11-27 17:55
1mo ago
|
Green Impact Partners Announces Full Commitments for Life Financing | stocknewsapi |
GIPIF
|
|
|
November 27, 2025 5:55 PM EST | Source: Green Impact Partners
Calgary, Alberta--(Newsfile Corp. - November 27, 2025) - Green Impact Partners Inc. (TSXV: GIP) ("GIP" or the "Company") is pleased to announce that the Company has received subscriptions from investors for the maximum amount set under the Listed Issuer Financing Exemption (LIFE) offering of $5.0 million at $4.00 per share and expects funding, including formal approval from the TSX Venture Exchange, within the coming business days. "We are extremely excited to complete this transaction as part of our near-term milestones. GIP looks forward to closing on the break fee transaction, the replacement of our senior debt, and potential asset sale transactions over the near term so that we can proceed with financial close and construction start of the Future Energy Park," said Jesse Douglas, Chief Executive Officer. In addition, GIP has filed its third quarter results, which are available on SEDAR+ at www.sedarplus.ca and the Company's website. About Green Impact Partners Inc. Green Impact Partners Inc. is forging a path towards a sustainable future by turning waste into energy. With a focus on renewable natural gas (RNG) and bioenergy projects, our mission is to acquire, develop, construct, and operate facilities that not only produce energy but also play an important role in waste reduction and lowering emissions. Our comprehensive approach spans the entire project life cycle, from idea generation through construction to ongoing operations. In addition to our RNG and bioenergy projects, GIP maintains a current portfolio of water and solids treatment and recycling facilities in Canada, alongside a solids recycling business in the United States. The Company is traded on the TSX Venture Exchange under the symbol 'GIP'. For more information about the Company, please visit www.greenipi.com. Cautionary Statements This news release contains forward-looking statements and/or forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. When used in this release, such words as "would", "will", "anticipates", "believes", "estimates", "explores", "expects" and similar expressions, as they relate to GIP, or its management, are intended to identify such forward-looking statements. Such forward-looking statements reflect the current views of GIP with respect to future events, and are subject to certain risks, uncertainties and assumptions. Many factors could cause GIP's actual results, performance or achievements to be materially different from any expected future results, performance or achievement that may be expressed or implied by such forward-looking statements. Certain information and statements contained in this news release constitute forward-looking statements, which reflects the Company's current expectations regarding future events, including but not limited to: completion of the break fee transaction; the replacement of the Company's senior debt; the anticipated sale of the Company's water, waste treatment, and recycling facilities; the timing and completion of the offering; and the securing of necessary regulatory and exchange approvals. Forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: the high degree of uncertainties inherent to feasibility and economic studies which are based to a significant extent on various assumptions; variations in commodity prices and exchange rate fluctuations; variations in cost of supplies and labour; lack of availability of qualified personnel; receipt of necessary approvals; availability of financing for project development; uncertainties and risks with respect to developing RNG projects; general business, economic, competitive, political and social uncertainties; assurance that the final terms will align with those initially agreed upon or that the transaction will proceed as anticipated; timeline of construction and ultimate completion of the Future Energy Park project; change in demand for clean energy to be offered by the Company; obtaining required approvals of regulatory authorities; general liquidity of the Company; ability to make obligations to its lenders; ability to access sufficient capital from internal and external sources; closing of the transaction referenced herein. For a more fulsome list of risk factors please see the Company's December 31, 2024, year-end Management Discussion and Analysis ("MD&A"), available on SEDAR+ at www.sedarplus.ca. Management of the Company has included the above summary of assumptions and risks related to forward-looking statements provided in this release to provide shareholders with a more complete perspective on the Company's current and future operations and such information may not be appropriate for other purposes. The Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements included in this news release should not be read as guarantees of future performance or results. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements, except in accordance with applicable securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276230 |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 15:38
1mo ago
|
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones | stocknewsapi |
MBX
|
|
|
One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term investors should take from that divergence.
On November 14, MPM BioImpact disclosed in a Securities and Exchange Commission filing that it sold out its entire stake in MBX Biosciences (MBX +7.03%), reducing exposure by an estimated $14.8 million. What HappenedAccording to a filing with the Securities and Exchange Commission dated November 14, MPM BioImpact sold its entire position in MBX Biosciences during the third quarter. The fund exited 1,294,416 shares, eliminating its exposure and reducing reportable U.S. equity holdings by an estimated $14.8 million based on quarterly average pricing. What Else to KnowTop holdings after the filing: NASDAQ:MDGL: $46.1 million (7.5% of AUM)NASDAQ:CGEM: $45.4 million (7.4% of AUM)NASDAQ:RNA: $33.1 million (5.4% of AUM)NASDAQ:TRVI: $31.2 million (5.1% of AUM)NASDAQ:EWTX: $27.9 million (4.6% of AUM)As of Wednesday's market close, MBX shares were priced at $33.82, up 71% over the past year and well outperforming the S&P 500, which is up 13% in the same period. Company OverviewMetricValuePrice (as of market close Wednesday)$33.82Market capitalization$1.5 billionNet income (TTM)($80.5 million)One-year price change71%Company SnapshotMBX Biosciences develops precision peptide therapies targeting endocrine and metabolic disorders, with lead candidates including MBX 2109 for chronic hypoparathyroidism, MBX 1416 for post-bariatric hypoglycemia, and MBX 4291 for obesity and related conditions. The company operates a clinical-stage biopharmaceutical business model, generating value through research, development, and potential future commercialization or licensing of proprietary drug candidates. Primary customers are expected to include healthcare providers, endocrinologists, and specialty clinics treating metabolic and endocrine disorders, with an eventual focus on patients requiring long-acting hormone therapies. Foolish TakeMBX has been one of the more volatile names in the biotech space, plunging roughly 75% from its September 2024 IPO through this March before rebounding sharply on strengthening clinical data and renewed investor interest. The stock now trades above its IPO price, reflecting a very different risk profile than it had just months ago. According to the latest SEC filing, MPM sold all its stake in MBX—nearly 1.3 million shares—during the third quarter, an estimated $14.8 million reduction in a name that previously represented a meaningful allocation. The firm also exited MoonLake Immunotherapeutics and Crinetics Pharmaceuticals during the same period, signaling broader repositioning across its emerging-biotech exposure. For its part, MBX continues to advance its pipeline: In the third quarter, the company reported positive topline Phase 2 results for canvuparatide in hypoparathyroidism, completed a $200 million upsized offering, and ended the quarter with $391.7 million in cash, which the firm says is enough to fund operations into 2029. CEO Kent Hawryluk highlighted the momentum, noting, “These strong results support our belief that canvuparatide has the potential to be best-in-class in hypoparathyroidism, an estimated multibillion-dollar market.” He also emphasized the drug's upcoming Phase 3 initiation and key 2026 milestones. For long-term investors, the message is clear: MBX is accelerating toward multiple pivotal catalysts, but its path remains highly data-dependent. Glossary13F reportable assets: Assets disclosed by institutional investment managers in quarterly SEC Form 13F filings, showing U.S. equity holdings. Assets under management (AUM): The total market value of investments managed by a fund or investment firm. Exposure: The amount of capital or percentage of a portfolio invested in a particular asset or sector. Net position change: The difference in the value or number of shares held in a security after a trade or series of trades. Clinical-stage biopharmaceutical: A company focused on developing drugs that are being tested in human clinical trials but are not yet approved for sale. Prodrug technology: A drug design approach where an inactive compound is converted into an active drug within the body. Precision peptide therapies: Targeted treatments using short chains of amino acids (peptides) designed for specific biological effects. Phase 2: The second stage of clinical trials, assessing a drug’s effectiveness and side effects in patients. Preclinical: Research and testing of a drug candidate in the laboratory or in animals before human trials begin. Licensing: Granting rights to another company to develop, manufacture, or sell a product, often in exchange for fees or royalties. Endocrine disorders: Medical conditions involving hormone-producing glands, affecting metabolism, growth, or other body functions. TTM: The 12-month period ending with the most recent quarterly report. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:00
1mo ago
|
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC | stocknewsapi |
QNTM
|
|
|
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 has aired Part 2 of a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation.
Award-winning CTV News journalist and W5 investigative reporter Jon Woodward provides highlights of Part Two of the series in an article entitled, “‘Something was wrong’: Inside a Canadian biotech firm’s fight to prove ‘stock spoofing’”. The series explores the phenomenon of “stock spoofing,” a market manipulation tactic that is illegal in Canada and the United States, and the basis of a USD $700 million lawsuit by Quantum Biopharma against two of Canada’s largest banks, CIBC and RBC. The second of the three-part W5 investigative series can be viewed today on CTV News at: W5: Quantum BioPharma seeks $700M in stock spoofing lawsuit. Part 1 can be viewed at: W5: MS research derailed by stock market spoofing: lawsuit. Quantum BioPharma Chief Executive Officer Zeeshan Saeed commented, “We thank W5 for their important investigation into the illegal, but little known, practice of stock spoofing and some of its harmful effects on retail investors. Our goal has always been to bring Lucid-MS – a potentially game-changing drug that in animal studies has been shown to stop and even reverse the degradation of nerve cells (a hallmark of multiple sclerosis) giving back mobility and control to the body unlike any drug today for the benefit of millions of people around the world who courageously live with this progressive and debilitating disease. By shining a light on our experience with alleged stock market manipulation, we hope to prevent other companies, their shareholders and their beneficiaries, from experiencing what we have been through.” Quantum BioPharma Co-Executive Chair, Anthony Durkacz added, “The basis of our USD $700 million lawsuit against CIBC and RBC is that we are alleging Canadian exchange trading data clearly show stock spoofing on a massive scale intended to manipulate Quantum BioPharma’s stock price. It is the banks and the brokers that have the responsibility to act as gatekeepers, and to ensure that their clients and their traders are not breaching trading rules and regulations, or engaging in illegal activity such as stock spoofing. We are alleging that at least 16 million illegal and fictitious orders came from Canadian bank platforms.” For more information visit: www.quantumbiopharma.com About Quantum BioPharma Ltd. Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd™ and spun out its OTC version to a company, Celly Nutrition Corp. (“Celly Nutrition”), now Unbuzzd Wellness Inc., led by industry veterans. Quantum BioPharma retains ownership of 19.86% as of September 30, 2025 of Unbuzzd Wellness Inc. at www.unbuzzd.com. The agreement with Unbuzzd Wellness Inc. also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. For more information visit www.quantumbiopharma.com. Forward-Looking Information This press release contains certain "forward-looking statements" within the meaning of applicable securities law. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as “believes”, “hopes”, “alleges”, “pending”, “further”, or variations of such words and phrases or statements that certain actions events or results “may”, “could”, “which”, or “will” and similar expressions) are not statements of historical fact and may be forward-looking statements. Forward-looking information herein includes, but is not limited to, statements regarding: the Company’s ongoing litigation against major financial institutions; the potential outcome or judgment value; expectations regarding whistleblower submissions and related rewards; continued market integrity initiatives; future business performance and possible acquisitions. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation: the ability to obtain and validate whistleblower evidence; the timing and outcome of legal proceedings; resolution of ongoing litigation on favourable terms, availability and sufficiency of litigation funding; continued regulatory compliance and market stability for the Company’s operations. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the adverse outcome of legal actions; the receipt and credibility of whistleblower disclosures; changes in applicable laws and regulations; the actions of third parties involved in alleged manipulation; evolving market dynamics; the sufficiency of future litigation proceeds to fund the Company’s whistleblower reward; the continued ability to obtain sufficient litigation funding; limited future growth opportunities, and reliance on key personnel. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. The reader is urged to refer to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at www.sedarplus.ca and on the EDGAR section of the SEC's website at www.sec.gov for a more complete discussion of such risk factors and their potential effects. Contacts: Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board Email: [email protected] Telephone: (833) 571-1811 Investor Relations Investor Relations: [email protected] General Inquiries: [email protected] |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:00
1mo ago
|
'Green light' away from AI trade: Two ETF executives see a key market shift underway | stocknewsapi |
EEM
XLI
|
|
|
watch now
A key rotation away from artificial intelligence stocks may be underway in the market. According to Astoria Portfolio Advisors' John Davi, a broader range of stocks are getting a "green light" because liquidity is returning to the system. "The Fed cut rates four times last year. They cut rates twice already. They're going to go again whether its December [or] January," the firm's CEO and chief investment officer told CNBC's "ETF Edge" this week. "Historically whenever the Fed cuts interest rates, usually that's a turn of a new cycle. Market leadership does tend to change quietly." He lists the latest performance in areas ranging from emerging markets to industrials. The iShares MSCI Emerging Markets ETF, which tracks the group, is up 17% over the past six months as of Wednesday's close. The Industrial Select Sector SPDR Fund is up 9% over the same period. "I think they can be a good offset to what's an expensive large cap tech position, which dominates most portfolios," he added. "We're living in a structurally higher inflation world. The Fed is cutting rates like, why do you want to take so much risk in just seven stocks?" and Davi prefers a global balanced approach to investing versus an overweight position in the Magnificent 7 — which is comprised of Apple, Amazon, Meta Platforms, Nvidia, Microsoft, Tesla and Alphabet, which has been trading around all-time highs. The Mag 7 makes up about a third of the S&P 500. Sophia Massie, CEO of ETF-issuer LionShares, is also wary of going all-in on the AI trade. "I think analysts have an idea of how much value AI will add to our economy. I don't think we really understand how that's going to play out between different companies yet," Massie said in the same interview. "So, I have this sense that right now, we're pricing in this probability that... one company may be the one that dominates, dominates AI and ends up being a big player in the future." |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:00
1mo ago
|
J&J Snack Foods (JJSF) CEO on Adding Protein to Pretzels | stocknewsapi |
JJSF
|
|
|
Dan Fachner, CEO of J&J Snack Foods (JJSF), walks through their latest quarter. “We had some mixed results, but some strength as we talk about going into 2026.” The company, which owns brands like Dippin' Dots, Icee, SuperPretzel, and more, is going through a transformation plan. He discusses product innovation, consumer demand and changing tastes, and highlights growth in their pretzels.
|
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:03
1mo ago
|
BuildDirect.com Technologies Inc. (BILD:CA) Q3 2025 Earnings Call Transcript | stocknewsapi |
BDCTF
BILD
|
|
|
BuildDirect.com Technologies Inc. (BILD:CA) Q3 2025 Earnings Call November 27, 2025 1:30 PM EST
Company Participants Shawn Wilson - Chief Executive Officer John Allen - Chief Operating & Integration Officer Kerry Biggs - Chief Financial Officer Presentation Unknown Attendee All right. Let's begin. Hello, everyone. Welcome to BuildDirect's Q3 2025 Financial Results Conference Call. For those who aren't familiar, BuildDirect trades on the TSXV under ticker BILD, that's B-I-L-D, BILD. And on the OTCQB under ticker symbol BDCTF. My name is Bob Chen, and I'll be the moderator for today's call. Before we begin, I would like to note that some of the comments today will contain forward-looking information and statements under applicable securities law that reflect management's current views with respect to future events. Any such information and statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those projected in the forward-looking information and statements. Please refer to the various materials the company has filed with the Canadian securities regulators for a broader description of operational and risk factors that could affect the company's performance. In addition, please note that all dollar amounts mentioned in the presentation are in U.S. dollars, unless otherwise stated. On today's call, we'll be covering BuildDirect's Q3 2025 financial and operational highlights as well as its growth outlook for the remainder of '25 and 2026. Following comments from BuildDirect's management, the call will be open for questions. [Operator Instructions] If you're calling in to listen to this webinar, please e-mail your questions directly to [email protected]. Our presenters today will be the CEO of BuildDirect, Shawn Wilson; CFO, Kerry Biggs; and COIO, Jay Allen. I will now turn the conference call over to Shawn. Shawn Wilson Chief Executive Officer Thanks, Bob, and to everyone joining us today, welcome. Let me start with Recommended For You |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:05
1mo ago
|
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference | stocknewsapi |
NYXH
|
|
|
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 2025. The fireside chat is scheduled at 1:30 p.m. (ET) the same day via webcast. A live audio webcast of the presentation will be available online at the investor relations page of the Company’s website at investors.nyxoah.com. About Nyxoah Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest. Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65. For more information, please visit http://www.nyxoah.com/. Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device. Contact: Nyxoah John Landry Chief Financial Officer [email protected] Rémi Renard Chief Investor Relations & Corporate Communication Officer [email protected] ENGLISH_NYXH Piper Conf Advisory PR_2025 |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:05
1mo ago
|
Giant Mining Corp. Appoints John Percival as Non-Executive Chairman | stocknewsapi |
BFGFF
|
|
|
VANCOUVER, BC — TheNewswire - November 27, 2025 — Giant Mining Corp. (CSE: BFG | OTC: BFGFF | FWB: YW5 | CSE: BFG.WT.A | CSE: BFG.WT.B) (“Giant Mining” or the “Company”) is pleased to announce the appointment of Mr. John Percival as Non-Executive Chairman of the Board of Directors. Mr. Percival brings more than five decades of global capital markets experience, with an extensive history of raising over $1 billion for public companies. He has a deep and influential presence in Australian financial markets, one of the largest and most active global capital hubs for mining investment, with over $12–15 billion typically raised annually across the mining and exploration sector. During 2024 and 2025, Australian mining markets experienced significant inflows driven by copper, uranium, critical metals, and gold, making Australia the most active global jurisdiction for junior and mid-tier mining financing.
|
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:15
1mo ago
|
G2 Goldfields Announces Voting Results from Its Shareholders Meeting | stocknewsapi |
GUYGF
|
|
|
November 27, 2025 16:15 ET
| Source: G2 Goldfields Inc. TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) and G3 Goldfields Inc. (“G3”) are pleased to announce that at G2’s annual general and special meeting of shareholders (the “Meeting”) held earlier today, the G2 shareholders approved the annual general matters as well as the matters relating to the proposed spin-out of G2’s interest in certain non-core assets (“Non-Core Assets”) into G3, a wholly owned subsidiary of G2, through a plan of arrangement under the Canada Business Corporations Act (the “Spin-Out”). Voting Results A total of 190,251,811 common shares of G2 (“G2 Shares”) were voted in person or represented by proxy at the Meeting, representing approximately 74.03% of the votes attached to all the outstanding G2 Shares as at the record date of the Meeting. ResolutionNumber of G2 SharesPercentage of Votes CastForAgainstForAgainstElection of Directors J. Patrick Sheridan185,880,3071,475,44299.21%0.79%Daniel Noone181,145,5126,210,23796.69%3.31%Bruce Rosenberg157,663,39929,692,35084.15%15.85%Stephen Stow186,170,8321,184,91799.37%0.63%Carmen Diges173,849,87113,505,87892.79%7.21%Re-appointment of MNP LLP as auditors of the Company and authorization for the board of directors to fix their remuneration190,218,95332,858 (withheld)99.98%0.02% (withheld)Approval of a plan of arrangement pursuant to which the Company will complete the Spin-Out187,274,62381,12699.96%0.04%Approval of stated capital reduction187,203,380152,36999.92%0.08%Approval of J. Patrick Sheridan as a new control person of G3 (excluding shares held by Mr. Sheridan)142,784,6713,522,00497.59%2.41%Approval of G3 stock option plan152,985,18634,370,56381.66%18.34%Approval of G3 restricted share unit plan186,064,5741,291,17599.31%0.69% The report of voting results will be made available under the Company’s profile on SEDAR+ (www.sedarplus.ca). Spin-Out Update The court hearing for the final order to approve the Spin-Out is scheduled to take place on December 3, 2025. The Spin-Out remains subject to final court and regulatory approvals, including final approval of the Toronto Stock Exchange. Additional details of the Spin-Out are more fully described in the management information circular of the Company dated October 23, 2025 (the “Circular”), which is available under G2’s profile on SEDAR+ at www.sedarplus.ca. The Spin-Out is expected to be completed in Q1 of 2026 following anticipated receipt of all court and regulatory approvals. Pursuant to the terms of the Spin-Out, G2 will, among other things, transfer (i) its interests in the Non-Core Assets to a wholly owned Guyanese subsidiary of G3, and (ii) a sufficient amount of cash to G3 (such amount to be determined by G2 at the relevant time) to satisfy G3’s working capital and initial listing requirements (which the Company anticipates to be approximately C$15 million) in exchange for G3 common shares (“G3 Shares”) and G2 will distribute such G3 Shares to its shareholders on the basis of one G3 Share for every two G2 Shares held as of the effective date of the Spin-Out. Only shareholders of G2 as of the close of business on the effective date of the Spin-Out will be entitled to receive G3 Shares. Further details on the effective date of the Spin-Out will be provided in Q1 2026. There will be no change in shareholders’ holdings in G2 as a result of the Spin-Out. About G2 Goldfields Inc. G2 Goldfields finds and develops gold deposits in Guyana. The founders and principals of the Company have been directly responsible for the discovery of more than 10 million ounces of gold in the prolific and underexplored Guiana Shield. G2 continues this legacy of exploration excellence and success. In March 2025, G2 announced an Updated Mineral Resource Estimate (“MRE”) for the Oko property in Guyana [see press release dated March 10, 2025]. Highlights of the Updated MRE include: Total combined open pit and underground Resource for the Oko Main Zone (OMZ): 513,500 oz. Au – Inferred contained within 3,473,000 tonnes @ 4.60 g/t Au808,000 oz. Au – Indicated contained within 3,147,000 tonnes @ 7.98 g/t Au Total combined open pit and underground Resource for the Ghanie Zone: 1,024,500 oz. Au – Inferred contained within 12,062,000 tonnes @ 2.64 g/t Au663,400 oz. Au – Indicated contained within 10,288,000 tonnes @ 2.01 g/t Au Total open pit Resource for the Oko NW Zone: 97,200 oz. Au – Inferred contained within 4,976,000 tonnes @ 0.61 g/t Au The MRE was prepared by Micon International Limited with an effective date of March 1, 2025. The Oko district has been a prolific alluvial goldfield since its initial discovery in the 1870s, and modern exploration techniques continue to reveal the considerable potential of the district. All scientific and technical information in this news release has been reviewed and approved by Dan Noone (CEO of G2 Goldfields Inc.), a “qualified person” within the meaning of National Instrument 43-101. Mr. Noone (B.Sc. Geology, MBA) is a Fellow of the Australian Institute of Geoscientists. Additional information about the Company is available on SEDAR+ (www.sedarplus.ca) and the Company's website (www.g2goldfields.com). On behalf of the Board of G2 Goldfields Inc. “Daniel Noone” CEO & Director For Further Information Jacqueline Wagenaar, VP Investor Relations Direct: +1.416.628.5904 x.1150 Email: [email protected] Forward-Looking Statements This news release contains certain forward-looking statements, including, but not limited to, statements about the Spin-Out, including the basis of the Spin-Out, the impact and benefits of the Spin-Out, the completion of the Spin-Out on the proposed terms or at all, the timing of completion of the Spin-Out, the required approvals, and the future plans and intentions of G2 and G3. Wherever possible, words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “schedule”, “anticipate”, “believe”, “estimate”, “predict” or “potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof. Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements, including the risk factors set out in the Company’s annual information form for the year ended May 31, 2025 and the Circular. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. The Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:15
1mo ago
|
Orca Energy Group Inc. Announces Completion of Q3 2025 Interim Filings | stocknewsapi |
ORXGF
|
|
|
TORTOLA, British Virgin Islands, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Orca Energy Group Inc. (“Orca” or the “Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announces that it has filed its condensed consolidated interim financial statements and management's discussion and analysis for the three and nine month periods ended September 30, 2025 (“Q3 2025”) with the Canadian securities regulatory authorities. All amounts are in United States dollars (“$”) unless otherwise stated.
Jay Lyons, Chief Executive Officer, commented: “Orca delivered strong operational results in Q3 2025, with gas deliveries rising 7% over the quarter and 4% year-to-date. The growth was driven by higher industrial consumption and increased demand for our services and products.” “The Company ended the period with cash and cash equivalents of $127.9 million and working capital of $56.2 million, supported by the collection of arrears from TANESCO under the April 2025 Settlement Agreement.” “We continue to actively manage the ongoing legal proceedings in Tanzania, remaining focused on protecting the Company's rights and our shareholders' interests. Looking ahead, Orca will keep its capital expenditures and allocation under review as we look to continue to focus on safety, essential maintenance, and cost efficiency across our operations.” Highlights Revenue decreased by 12%, or $3.0 million, for Q3 2025 and by 4%, or $3.3 million, for the nine months ended September 30, 2025 over the comparable prior year periods, primarily as a result of the increases in the Tanzanian Petroleum Development Corporation (“TPDC”) share of revenue as an outcome of decreased capital expenditures and lower Cost Gas revenue (as defined in the Management's Discussion & Analysis for the three and nine months ended September 30, 2025) recoveries by the Company.Gas deliveries increased by 7%, or 4.7 MMcfd, for Q3 2025 and by 4%, or 2.7 MMcfd, for the nine months ended September 30, 2025 compared to the same prior year periods. The increases were mainly a result of increased consumption by industrial customers due to a higher demand for services and products. Additionally, the end of the Protected Gas (defined below) regime Q3 2024 resulted in higher deliveries of Additional Gas (defined below) to Tanzania Portland Cement PLC (“TPCPLC”) from August 2024 onward. This was partially offset by the completion of the Julius Nyere Hydropower Project in 2024 leading to increased availability of hydro power and causing lower lifting from power customers.On August 7, 2024, PanAfrican Energy Tanzania Limited (“PAET”) and Pan African Energy Corporation (Mauritius) (“PAEM”) issued a notice of dispute (the “Notice of Dispute”) in respect of an investment treaty claim against the Government of Tanzania (the “GoT”) for breach of the Agreement on Promotion and Reciprocal Protection of Investment between the Government of the Republic of Mauritius and the GoT (the “BIT”), and a contractual dispute against the GoT and TPDC, for breaches of the: (i) the Production Sharing Agreement between PAET, TPDC and the GoT (the “PSA”), and (ii) the Gas Agreement between the GoT, TPDC, Songas Limited (“Songas”) and PAET (the “Gas Agreement”). Initial meetings with both the Advisory and Coordinating Committees were held during the week of October 14, 2024 without any resolution on the key issues in dispute. The matters have been further referred to the relevant entity’s chief executive officers and working groups in accordance with the dispute resolution process. Discussions continued with meetings held in January and March 2025 without resolution. The Company’s Counsel subsequently submitted a letter to the Ministry of Energy (the “MoE”), requesting an urgent meeting to address the issues. In July 2025, our counsel received a letter from the Permanent Secretary to the MoE, dated June 26, 2025, advising PAET that the MoE was working on the Songo Songo Development License (the “License”) extension application and that feedback would be available in due course. The letter also advised against interference in the independence of the MoE, in the interests of good governance and proper processing of the application. The Company’s Counsel submitted a response to the MoE advising that the approaches made to the MoE were reasonable and proportionate enquiries into the status of the application, given the lengthy inaction and engagement to date. The letter urged immediate engagement to resolve the matter of the License extension. The MoE has recently proposed the parties meet to discuss the current License and terms of a License extension proposal submitted by TPDC to be made for consideration by the Minister and GoT. The Company has requested the MoE submit an economically viable proposal for review before parties agree to meet. To date, no proposal in response to this request has been received.On April 15, 2025, PAET and TPDC signed a settlement agreement with the Tanzanian Electric Supply Company Limited (“TANESCO”) (the “Settlement Agreement”), for TANESCO to pay PAET $52.0 million for unpaid amounts owing by TANESCO for deliveries of natural gas from the Songo Songo gas field and late payment interest, which unpaid amounts totaled $104,164,507.41 as of January 9, 2025, comprising of $33.7 million of principal amount owing and approximately $70.5 million of default interest. The Settlement Agreement required TANESCO to pay the Tanzanian Shilling equivalent of $52.0 million, comprised of the $33.7 million principal amount and $18.3 million representing a portion of the default interest owed by TANESCO. It was agreed that the remaining balance of the default interest owing by TANESCO would be waived if TANESCO paid the settlement amount when required and in full while remaining current on amounts owed. As at September 30, 2025, TANESCO has paid the full $52.0 million due under the Settlement Agreement, and the Company has duly waived the remaining balance of the default interest owing by TANESCO. Payments on account of the settlement amount have been allocated between PAET and TPDC in accordance with the PSA. Pursuant to the PSA, the Company has retained approximately $35.5 million of the settlement amount with TPDC receiving the balance.Net income attributable to shareholders increased by 834%, or $17.4 million, for Q3 2025 and by 889%, or $37.7 million, for the nine months ended September 30, 2025 compared to the same prior year periods, primarily as a result of the reversal of loss allowance and the recognition of interest income following the collection of TANESCO long-term arrears and default interest pursuant to the Settlement Agreement.Net cash flows from operating activities increased by 215%, or $22.0 million, for Q3 2025 and by 306%, or $63.7 million, for the nine months ended September 30, 2025 compared to the same prior year periods primarily as a result of higher payments from TANESCO in Q2 2025 and Q3 2025 pursuant to the Settlement Agreement.Capital expenditures decreased by 98%, or $9.2 million, for Q3 2025 and by 94%, or $12.0 million, for the nine months ended September 30, 2025 compared to the same prior year periods. The capital expenditures in Q1, Q2 and Q3 2025 primarily related to the costs of flowlines replacements on SS-5 and SS-9 wells, deferred from 2024 at the request of the GoT. Following the successful replacement of the SS-9 flowline, the flowline replacement program for the SS-5 well was further deferred to Q4 2025. Inclement weather through the wet season and SE (Kusini) winds caused delay to the completion of the project and with it the employment of some capital. Given the lump-sum costs for the project, total capital expenditure is not expected to increase when the project resumes in Q4 2025. The capital expenditures in Q1, Q2 and Q3 2024 primarily related to the costs of the SS-7 well workover program.The Company exited Q3 2025 with $56.2 million in working capital (December 31, 2024: $21.9 million) and cash and cash equivalents of $127.9 million (December 31, 2024: $90.1 million). Cash held in hard currencies (USD, Euro, GBP, CDN) was $117.3 million, as at September 30, 2025 (December 31, 2024: $87.1 million). Of the total cash balance of $127.9 million, $24.7 million was posted as security in respect to an appeal initiated by the Company relating to a judgment received from the Tanzania High Court (Commercial Division) for a claim brought by a contractor against PAET relating to alleged losses arising from PAET’s termination of a contract relating to the Company’s 3D seismic acquisition program. PAET is currently appealing the judgement.The TANESCO long-term receivable as at December 31, 2024 was $22.0 million and had been fully provided for. As at September 30, 2025, the Company has received all amounts due under the Settlement Agreement. Accordingly, the provision has been reversed in full and the long-term receivable balance as at September 30, 2025 is $ nil. Subsequent to September 30, 2025, the Company has invoiced TANESCO $4.8 million for October 2025 gas deliveries and TANESCO has paid the Company $4.5 million.On April 25, 2025, Swala Oil & Gas (Tanzania) Plc, in liquidation (“Swala”) submitted a claim to the Tanzania High Court (the “Court”) against Orca, PAEM and PAET for alleged breach of oral contract, unlawful conspiracy, unjust enrichment and breach of fiduciary duty. Swala claims damages of approximately $237,930,013 in addition to pre- and post-judgment interest. This breaks down to: (i) $167,930,013 for damages arising from breach of contract or conspiracy; (ii) $50.0 million for general damages, and (iii) $20.0 million for punitive and exemplary damages. The Company believes there is no merit to the claim (the “Swala Dispute”). In August 2025, ORCA, PAEM, and PAET filed a security for costs application against Swala. The Court is scheduled to rule on this application on November 21, 2025. If successful, and if Swala fails to pay any ordered security within the requisite period of time, the Swala Dispute will be dismissed. In September 2025, Swala filed an application (the “Prejudgment Application”) seeking certain prejudgment orders: (a) an Order that Orca, PAEM, and PAET pay the entire specified damages amount of $167,930,013 (which has not been proven) as security, or (b) in the alternative, an order for the attachment of all PAET bank accounts in Tanzania, or (c) in the further alternative an order requiring: (i) Orca not to pay any money to any owner of Class A Common Shares, Class B Subordinate Shares, First Preference Shares, an interest in Orca's Long-term Retention Plan, or an owner in any new securities created or issued by Orca, (ii) requiring PAEM not to transfer any money in any manner or purpose, to any bank outside of the Republic of Mauritius other than to comply with third-party obligations in the normal course of business, and (iii) requiring PAET not to transfer any money to any bank outside of Tanzania other than to comply with third-party obligations in the normal course of business. The relief sought in the Prejudgment Application is extraordinary and the law requires Swala to strictly satisfy the requisite legal conditions of cogent evidence. The Company does not believe Swala has done so. The next court appearance for the Prejudgment Application is scheduled for December 8, 2025, where this matter will come up "for mentions", following which a hearing on the merits of the Prejudgment Application will need to be scheduled.On 24 October 2025, the Company filed an anti-suit injunction (the “ASI”) against Swala on behalf of Orca, PAEM, and PAET in the High Court of England and Wales Commercial Court, seeking to enjoin Swala from taking steps to pursue the Swala Dispute in Tanzania. If successful, and if Swala fails to comply with the order, its failure may result in a finding of contempt of court and exposure for both Swala and the liquidator to commercial and criminal sanctions.On August 1, 2025, PAEM submitted a Request for Arbitration (an “RFA”) to the International Centre for Settlement of Investment Disputes (“ICSID”), an arm of the World Bank, against the GoT for various breaches of the investment protections provisions of the BIT; and PAET submitted two separate RFA’s to ICSID against the GoT and TPDC for breaches of the PSA and the Gas Agreement. The three claims (the “Claims”) arise out of a series of actions and omissions by Tanzania and TPDC that threaten the viability of the Songo Songo Gas-to-Electricity Project (the “Project”) and breach multiple obligations under the BIT, the PSA and the Gas Agreement. On August 28, 2025, ICSID registered all three RFAs. PAEM has appointed its arbitrator for the BIT proceedings, and we expect the tribunal in this case to be constituted by the end of 2025. PAET, the GoT, and TPDC have agreed to consolidate the two proceedings brought under the PSA and the Gas Agreement, and once this consolidation is complete the parties will proceed with the tribunal appointment process.Considering the anticipated reduction in capital expenditure going forward, with safety and maintenance being the main focus for the remainder of the License, the Company intends to review its capital allocation policy in the near term and will update the market as appropriate. Financial and Operating Highlights for the Three and Nine Months Ended September 30, 2025 Three months ended September 30 % Change Nine months ended September 30 % Change (Expressed in $’000 unless indicated otherwise)2025 2024 Q3/25 vs Q3/24 2025 2024 Ytd/25 vs Ytd/24 OPERATING Daily average gas delivered and sold (MMcfd)71.1 66.4 7%70.5 67.8 4%Industrial20.9 17.7 18%19.5 14.8 32%Power50.2 48.7 3%51.0 53.0 (4)%Average price ($/mcf) Industrial7.79 8.71 (11)%7.86 8.94 (12)%Power3.95 3.89 2%3.96 3.87 2%Weighted average5.08 5.18 (2)%5.04 4.98 1%Operating netback ($/mcf)2.00 2.98 (33)%2.51 2.97 (15)% FINANCIAL Revenue21,746 24,787 (12)%71,411 74,738 (4)%Net income attributable to shareholders19,475 2,086 834%41,978 4,243 889%per share – basic and diluted ($)0.99 0.11 834%2.12 0.21 889%Net cash flows from operating activities32,294 10,255 215%84,506 20,832 306%per share – basic and diluted ($)1.63 0.52 215%4.28 1.05 306%Capital expenditures182 9,354 (98)%774 12,736 (94)%Weighted average Class A and Class B Shares (‘000)19,765 19,770 0%19,765 19,781 0% September 30, 2025 As at December 31, 2024 % Change Working capital (including cash) 56,161 21,904 156%Cash and cash equivalents 127,868 90,076 42%Outstanding shares (‘000) Class A 1,750 1,750 0%Class B 18,015 18,022 0%Total shares outstanding 19,765 19,772 0%See Non-GAAP Financial Measures and Ratios. Outlook The recent and widely reported civil unrest seen in Tanzania during October’s national elections did not impact our operations, and our 2025 volume guidance is unchanged. Although demand for gas declined slightly during the unfortunate events, GoT institutions, customers and other stakeholders quickly resumed business operations and demand has returned to normal levels. Guidance levels for production for 2026 are between 60 – 65 MMcfd. This decrease from 2025 is due to the field decline and seasonal variations due to hydro. There remains no tangible progress on the Songo Songo Licence extension application, as we continue to await meaningful engagement with the GoT, who have been asked, but are yet to, propose economically viable, commercially reasonable terms. Consequently, it is necessary to continue to pursue the arbitration process. Given the increasing uncertainty relating to the License extension, the assessment of the long-term sustainability of the Company’s business in Tanzania has been very significantly and negatively impacted. The combined effect of the GoT's actions and inactions, together with the proliferation of unfounded commercial disputes, has materially reduced confidence in the stability of the operating framework for the Songo Songo project and its long-term prospects. While domestic demand for natural gas remains strong, the Company’s ability to invest in development initiatives to sustain current demand and meet incremental demand is contingent on securing an extension of the Licence on commercially acceptable terms, within a predictable legal and regulatory environment, and achieving satisfactory resolution of the governmental and commercial disputes currently affecting the Company’s operations in Tanzania. Given these complex and challenging circumstances, the Board of Directors of Orca is undertaking a comprehensive strategic review to assess viable options to mitigate the risks described above and elsewhere in this news release and the Management, Discussion & Analysis for the nine-month period ended September 30, 2025 with the objective of protecting the Company's best interests and preserving or maximizing shareholder value. The forward-looking information in this Outlook section (i) assumes that the current delays in resolving the regulatory and contractual disputes affecting the Company's operations in Tanzania continue and (ii) is subject to the risks and uncertainties disclosed in the Company's Management, Discussion & Analysis for the 12-month period ended December 31, 2024 and the three and six-month periods ended March 31 and June 30, 2025 . To the extent required under applicable Canadian securities laws, management will revise its outlook if conditions change materially, or if previously disclosed forward-looking information becomes unreliable. The complete Condensed Consolidated Interim (Unaudited) Financial Statements and Notes and Management’s Discussion & Analysis for the three and nine months ended September 30, 2025 may be found on the Company’s website at www.orcaenergygroup.com or on the Company’s profile on SEDAR+ at www.sedarplus.ca. Orca Energy Group Inc. Orca Energy Group Inc. is an international public company engaged in natural gas development and supply in Tanzania through its subsidiary, PAET. Orca trades on the TSX Venture Exchange under the trading symbols ORC.B and ORC.A. The principal asset of Orca is its indirect interest in the PSA with TPDC and the GoT in the United Republic of Tanzania. This PSA covers the production and marketing of certain conventional natural gas from the License offshore Tanzania. The PSA defines the gas produced from the Songo Songo gas field as “Protected Gas” and “Additional Gas”. The Gas Agreement deals further with the parties’ entitlement to Protected Gas and Additional Gas. Under the Gas Agreement, until July 31, 2024, Protected Gas was owned by TPDC and was sold to Songas TPCPLC. After July 31, 2024, Protected Gas ceased and all production from the Songo Songo gas field constitutes Additional Gas which PAET and TPDC are entitled to sell on commercial terms until the PSA expires in October 2026. Songas is the owner of the infrastructure that enables the gas to be treated and delivered to Dar es Salaam, which includes a gas processing plant on Songo Songo Island. Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Abbreviations mcfthousand cubic feetMMcfmillion standard cubic feetMMcfdmillion standard cubic feet per day Non-GAAP Financial Measures and Ratios In this press release, the Company has disclosed the following non-GAAP financial measures, non-GAAP ratios and supplementary financial measures: capital expenditures, operating netback, operating netback per mcf, working capital, net cash flows from operating activities per share and weighted average Class A and Class B Shares. These non-GAAP financial measures and ratios disclosed in this press release do not have any standardized meaning under International Financial Reporting Standards (“IFRS”), and may not be comparable to similar financial measures disclosed by other issuers. These non-GAAP financial measures and ratios should not, therefore, be considered in isolation or as a substitute for, or superior to, measures and ratios of Company’s financial performance defined or determined in accordance with IFRS. These non-GAAP financial measures and ratios are calculated on a consistent basis from period to period. Non-GAAP Financial Measures Capital expenditures Capital expenditures is a useful measure as it provides an indication of our investment activities. The most directly comparable financial measure is net cash used in investing activities. A reconciliation to the most directly comparable financial measure is as follows: Three Months ended September 30 Nine Months ended September 30 $’0002025 2024 2025 2024 Pipelines, well workovers and infrastructure182 9,286 774 12,364 Other capital expenditures– 68 – 372 Capital expenditures182 9,354 774 12,736 Change in non-cash working capital334 (5,622) 9,518 (5,520)Net cash used in investing activities516 3,732 10,292 7,216 Operating netback Operating netback is calculated as revenue less processing and transportation tariffs, TPDC’s revenue share, and operating and distribution costs. The operating netback summarizes all costs that are associated with bringing the gas from the Songo Songo gas field to the market and is a measure of profitability. A reconciliation to the most directly comparable financial measure is as follows: Three Months ended September 30 Nine Months ended September 30 $’0002025 2024 2025 2024 Revenue21,746 24,787 71,411 74,738 Production, distribution and transportation expenses(4,479)(6,566) (12,857)(14,725)Net Production Revenue17,267 18,221 58,554 60,013 Less current income tax adjustment (recorded in revenue)(4,145)(38) (10,211)(4,756)Operating netback13,122 18,183 48,343 55,257 Sales volumes MMcf6,547 6,108 19,250 18,581 Netback $/mcf2.00 2.98 2.51 2.97 Non-GAAP Ratios Operating netback per mcf Operating netback per mcf represents the profit margin associated with the production and sale of Additional Gas and is calculated by taking the operating netback and dividing it by the volume of Additional Gas delivered and sold. This is a key measure as it demonstrates the profit generated from each unit of production. Supplementary Financial Measures Working capital Working capital is defined as current assets less current liabilities, as reported in the Company’s Condensed Consolidated Interim Statements of Financial Position (Unaudited). It is an important measure as it indicates the Company’s ability to meet its financial obligations as they fall due. Net cash flows from operating activities per share Net cash flows from operating activities per share is calculated as net cash flows from operating activities divided by the weighted average number of shares, similar to the calculation of earnings per share. Net cash flow from operations is an important measure as it indicates the cash generated from the operations that is available to fund ongoing capital commitments. Weighted average Class A and Class B Shares In calculating the weighted average number of shares outstanding during any period the Company takes the opening balance multiplied by the number of days until the balance changes. It then takes the new balance and multiplies that by the number of days until the next change, or until the period end. The resulting multiples of shares and days are then aggregated and the total is divided by the total number of days in the period. Forward-Looking Statements This press release contains forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. All statements, other than statements of historical fact included in this press release, which address activities, events or developments that Orca expects or anticipates to occur in the future, are forward-looking statements. Forward-looking statements often contain terms such as may, will, should, anticipate, expect, continue, estimate, believe, project, forecast, plan, intend, target, outlook, focus, could and similar words suggesting future outcomes or statements regarding an outlook. More particularly, this press release contains, without limitation, forward-looking statements pertaining to the following: the Company’s expectations regarding the demand for natural gas and power supply; costs, outcomes and timing in respect to the outcome of the Notice of Dispute and the Claims; costs, outcomes and timing in respect to the outcome of the Swala Dispute; merit, outcomes, position and timing in respect of the Notice of Dispute and Claims; expectations in relation to the Notice of Dispute and Claims; merit, outcomes, position and timing in respect of the Swala Dispute; expectations in relation to the Swala Dispute; the amount of damages that may be payable by the Company relating to the Swala Dispute; expectations in relation to the ASI; merit, outcomes, position and timing in respect of the ASI; the amount of damages that may be received by the Company in respect to the Claims; extension of the License and the Company’s expectation to continue to actively engage with the GoT to progress the License extension; the ability of the Company to continue its operating activities subsequent to October 2026, when the License is set to expire; continued accrual of participating interest in respect of the Loan until the specified date; the receipt of the payment of interest from TANESCO; the payment by TANESCO of amounts owing under the Settlement Agreement; and the amount that PAET is expected to retain in relation to the Settlement Agreement; the Company’s plans to provide updates on the Notice of Dispute, Claims, and/or Swala Dispute; that the flowlines project will resume in Q4 2025; and the Company's intention to review its capital allocation policy in the near term and will update the market as appropriate. Actual results may differ materially from those anticipated in the forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, access to resources and infrastructure, performance or achievement since such expectations are inherently subject to significant business, economic, operational, competitive, political and social uncertainties and contingencies. These forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company’s control, and many factors could cause the Company’s actual results to differ materially from those expressed or implied in any forward-looking statements made by the Company, including, but not limited to: uncertainties involving the Notice of Dispute, Claims and RFA’s, Swala Dispute, and the ASI; various uncertainties involved in the extension of the License; risk the PSA will not be replaced; risk of decreased demand for production volumes from the Songo Songo gas field; risk the Songas Power Plant will shut down indefinitely; negative effect on the Company’s rights under the PSA and other agreements relating to its business in Tanzania; fluctuations in demand for natural gas and power supply in Tanzania; the Company’s average gas sales including the sale of Additional Gas are different than anticipated; risk that the Company may incur losses and legal expenses as a result of the Notice of Dispute; risk that the Company may incur losses and legal expenses as a result of the RFA’s and Claims and/or the Swala Dispute; uncertainties regarding quantum of damages payable to the Company in respect of the Notice of Dispute and/or Claims; uncertainties regarding quantum of damages payable by the Company in respect of the Swala Dispute; risk that the budgeted expenditures, timing of the completion and anticipated benefits from the Company’s various development programs and studies in 2025 are different than expected; risk of damage to the Company’s infrastructure assets; failure to extend the License on favorable terms or at all; inability to continue the Company's operating activities beyond the expiry of the License; inability to maintain gas sale contract discipline; the accrual of participating interest is different than expected; failure to receive payment of arrears from TANESCO; risk that TANESCO will not pay such amounts owing under the Settlement Agreement; changes to forecasts regarding future development capital spending and source of capital spending; risk of future restrictions on the movement of cash from Jersey, Mauritius or Tanzania; occurrence of circumstance or events which significantly impact the Company’s cash flow and liquidity and the Company’s ability cover its long-term and short-term obligations or fund planned capital expenditures; incurrence of losses from debtors in 2025; prolonged foreign exchange reserves deficiency in Tanzania; inability to convert Tanzanian shillings into US dollars or other hard currencies as and when required; discontinuation of work by the Company with the GoT on an alternative development plan for longer term field development; failure to obtain necessary regulatory approvals; risks regarding the uncertainty around evolution of Tanzanian legislation; risk of unanticipated effects regarding changes to the Company’s tax liabilities and the implementation of further legislation and the Company’s interpretation of the same; risk of a lack of access to Songas processing and transportation facilities; failure to extend the License on favorable terms or at all; inability to continue the Company’s operating activities beyond the expiry of the License; risk that the Company may be unable to complete additional field development to support the Songo Songo production profile through the life of the License; risks associated with the Company’s ability to complete sales of Additional Gas; negative effect on the Company’s rights under the PSA and other agreements relating to its business in Tanzania as a result of recently enacted legislation, as well as the risk that such legislation will create additional costs and time connected with the Company’s business in Tanzania; risk relating to the Company’s relationship with the GoT; the impact of general economic conditions in the areas in which the Company operates; civil unrest; risk of pandemic; industry conditions; changes in laws and regulations including the adoption of new environmental laws and regulations; impact of local content regulations and variances in the interpretation and enforcement of such regulations; uncertainty regarding results through negotiations and/or exercise of legally available remedies; failure to successfully negotiate agreements; risks of non-payment by recipients of natural gas supplied by the Company; lack of certainty with respect to foreign legal systems, corruption, and other factors that are inconsistent with the rule of law; risk of loss due to acts of war, terrorism, sabotage and civil disturbances; timing of receipt of, or failure to comply with, necessary permits and approvals; and potential damage to the Company’s reputation due to the actual or perceived occurrence of any number of events, including negative publicity with respect to the Company’s dealings with the GoT, TPDC and TANESCO, whether true or not; increased competition; the lack of availability of qualified personnel or management; fluctuations in commodity prices, foreign exchange or interest rates; stock market volatility; competition for, among other things, capital, oil and gas field services and skilled personnel; failure to obtain required equipment or replacement parts for field development; effect of changes to the PSA on the Company as a result of the implementation of new government policies for the oil and gas industry; inaccuracy in reserve estimates; incorrect forecasts in production and growth potential of the Company’s assets; inability to obtain required approvals of regulatory authorities; risks associated with negotiating with foreign governments; failure to successfully negotiate agreements; risk that the Company will not be able to fulfil its contractual obligations; risk that trade and other receivables may not be paid by the Company’s customers when due; the risk that the Company’s Tanzanian operations will not provide near term revenue earnings; and such additional risks listed under “Business Risks” in our management discussion and analysis for the three and nine month periods ended September 30, 2025, and our management discussion and analysis for the year ended December 31, 2024. As a result of the foregoing, the Company’s actual results, performance or achievement could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by these forward-looking statements will transpire or occur, or if any of them do so, what benefits the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. Such forward-looking statements are based on certain assumptions made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors the Company believes are appropriate in the circumstances, including, but not limited to: increased demand for gas supply; successful negotiation and execution of new gas sales contracts under the Gas Agreement; successful negotiation of the License extension on terms favorable to the Company; successful implementation of various development and study programs at the budgeted expenditures; accurate assessment by the Company of the merits of its claim under the Notice of Dispute, Claims, the Swala Dispute, and the ASI; that all capital allocation decisions will be based upon prudent economic evaluations and returns; successful maintenance of gas sale contract discipline on a go-forward basis pursuant to the Company’s gas supply agreements; that the Company will receive payment of arrears from TANESCO; the Company’s relationship with TPDC and the GoT; the current status of actions involved in the Notice of Dispute, Claims and the Swala Dispute; accurate assessment by the Company of the merits of its rights and obligations in relation to TPDC and the GoT and other stakeholders in the Songo Songo gas field; receipt of required regulatory approvals; the Company’s ability to maintain strong commercial relationships with the GoT and other state and parastatal organizations and other stakeholders in the Songo Songo gas field; the current and future administration in Tanzania continues to honor the terms of the PSA and the Company’s other principal agreements; that there will continue to be no restrictions on the movement of cash from Mauritius, Jersey or Tanzania; that the Company will have sufficient cash flow, debt or equity sources or other financial resources required to fund its capital and operating expenditures and participation interest obligations as needed; the Company does not incur any losses from debtors in 2025; absence of circumstances or events that significant impact the Company’s cash flow and liquidity; the Company will continue to be able to convert Tanzanian shillings into US dollars; long term field development will be carried out as planned; continued work by the Company with the GoT on alternative development plan for longer term field development as anticipated; timing and amount of capital expenditures and source of funding are in line with forecasts; the Company’s ability to obtain necessary regulatory approvals; the anticipated supply and demand of natural gas are in line with the Company’s expectations; accurate assessment by the Company of the merits of the claims brought forward by the Company pursuant to the Claims and the RFA’s, and the Swala Dispute; that the amount of damages recoverable by the Company under the Notice of Dispute and Claims will be in line with expectations; the Company’s interpretation and prediction of the effects regarding changes to the Company’s tax liabilities and the implementation of further legislation is accurate in all material respects; the Company’s ability to obtain revenue earnings from its operations; access to customers and suppliers; availability of employees to carry out day-to-day operations, and other resources; that the Company will successfully negotiate agreements; receipt of required regulatory approvals; the ability of the Company to increase production as required to meet demand; infrastructure capacity; commodity prices will not deteriorate significantly; availability of skilled labour; uninterrupted access to infrastructure; the impact of increasing competition; conditions in general economic and financial markets; effects of regulation by governmental agencies; that the Company’s appeal of various tax assessments will be successful; current or, where applicable, proposed industry conditions, laws and regulations will continue in effect or as anticipated as described herein; the effect of any new environmental and climate change related regulations will not negatively impact the Company; and other matters. The forward-looking statements contained in this press release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:15
1mo ago
|
ESGold Corp. Announces Upsize of Flow-Through Share Private Placement to Gross Proceeds of up to C$4.5 Million | stocknewsapi |
ESAUF
|
|
|
November 27, 2025 4:15 PM EST | Source: ESGold Corp.
Vancouver, British Columbia--(Newsfile Corp. - November 27, 2025) - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) ("ESGold" or the "Company") is pleased to announce that as a result of strong investor demand, the Company has increased the maximum gross proceeds of its previously announced non-brokered private placement from $2,975,000 to $4,505,000 (the "Offering"). Pursuant to the Offering, the Company shall sell up to 5,300,000 flow-through common shares of the Company (the "FT Shares") at a price of $0.85 per FT Share. Red Cloud Securities Inc. is acting as an exclusive finder in connection with the Offering. The Company intends to use the proceeds from the Offering to fund the exploration of the Company's Montauban Property in Quebec. The gross proceeds from the sale of the FT Shares will be used for Canadian exploration expenses as defined in paragraph (f) of the definition of "Canadian exploration expense" in subsection 66.1(6) of the Income Tax Act (Canada) and will qualify as "flow-through mining expenditures", as defined in subsection 127(9) of the Income Tax Act (Canada) that will qualify as "flow-through mining expenditures" as defined in section 359.1 of the Taxation Act (Québec) (the "Qualifying Expenditures"), which will be incurred on or before December 31, 2026 and renounced to the purchasers of FT Shares with an effective date no later than December 31, 2025 in an aggregate amount not less than the gross proceeds raised from the issue of the FT Shares. The Company may pay finder's fees to eligible finders in connection with the Offering. The Offering is expected to close on or about December 8, 2025. Closing of the Offering is subject to various conditions, including receipt of all necessary corporate and regulatory approvals, including the Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. About ESGold Corp. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully permitted, fully funded, pre-production mining company advancing a scalable clean mining model across North and South America. The Company's flagship Montauban Gold-Silver Project in Quebec is under construction with production anticipated in 2026. ESGold is also advancing a joint venture in Colombia, validating one of South America's most prolific gold regions for tailings reprocessing and systematic exploration. With a dual-track strategy of cash flow today and discovery tomorrow, ESGold is building a platform for clean, sustainable growth and long-term shareholder value. For more information, please contact ESGold Corp. at +1-888-370-1059 or visit esgold.com for additional resources, including a French version of this press release, past news releases, a 3D model of the Montauban processing plant, media interviews, and opinion-editorial pieces. Stay connected by following us on X (formerly Twitter), LinkedIn, and joining our Telegram channel. For further information or to connect directly, please reach out to Gordon Robb, CEO of ESGold Corp. at [email protected] or call 250-217-2321. On behalf of the Board of Directors, ESGold Corp. Paul Mastantuono Chairman & COO [email protected] +1-888-370-1059 Forward-Looking Statements This news release contains "forward-looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements in this news release relate to, among other things: the proceeds from the Offering and the intended use thereof; the intention and timing related to incurring Qualifying Expenditures and the renunciation thereof; and the payment of possible finders fees. These forward-looking statements reflect the Company's current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable by the Company, are inherently subject to significant operational, business, economic and regulatory uncertainties and contingencies. These assumptions include, among other things: conditions in general economic and financial markets; accuracy of assay results; geological interpretations from drilling results, timing and amount of capital expenditures; performance of available laboratory and other related services; future operating costs; the historical basis for current estimates of potential quantities and grades of target zones; the availability of skilled labour and no labour related disruptions at any of the Company's operations; no unplanned delays or interruptions in scheduled activities; all necessary permits, licenses and regulatory approvals for operations are received in a timely manner; the ability to secure and maintain title and ownership to properties and the surface rights necessary for operations; and the Company's ability to comply with environmental, health and safety laws. The foregoing list of assumptions is not exhaustive. The Company cautions the reader that forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements contained in this news release and the Company has made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the timing and content of work programs; results of exploration activities and development of mineral properties; the interpretation and uncertainties of drilling results and other geological data; receipt, maintenance and security of permits and mineral property titles; environmental and other regulatory risks; project costs overruns or unanticipated costs and expenses; availability of funds; failure to delineate potential quantities and grades of the target zones based on historical data; general market and industry conditions; and those factors identified under the caption "Risks Factors" in the Company's continuous disclosure documents filed on SEDAR+ at www.sedarplus.ca. Forward-looking statements are based on the expectations and opinions of the Company's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made. The Company undertakes no obligation to update or revise any forward-looking statements included in this news release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law. Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276208 |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:15
1mo ago
|
Orca Announces Quarterly Dividend | stocknewsapi |
ORXGF
|
|
|
TORTOLA, British Virgin Islands, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Orca Energy Group Inc. (“Orca” or the “Company”) (TSX-V: ORC.A, ORC.B) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (Cdn) per Class A Common Voting Share ("Class A Shares") of the Company and $0.10 (Cdn) per Class B Subordinate Voting Share ("Class B Shares") of the Company. The dividend will be payable on January 14, 2026 to holders of Class A Shares and Class B Shares of record on December 31, 2025.
About Orca Energy Group Inc. Orca is an international public company engaged in natural gas exploration, development and supply in Tanzania through its subsidiary PanAfrican Energy Tanzania Limited. Orca trades on the TSX Venture Exchange under the trading symbols ORC.A and ORC.B. Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:17
1mo ago
|
Spetz Inc. Announces Corporate Name and Ticker Symbol Change | stocknewsapi |
DBKSF
|
|
|
November 27, 2025 4:17 PM EST | Source: Spetz Inc.
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Spetz Inc. ("Spetz" or the "Company") is pleased to announce the official approval of its rebranding to reflect its focus as a dedicated validator infrastructure operator for the Sonic blockchain. The Company will file articles of amendment in accordance with the Business Corporations Act (Ontario) and, effective December 2, 2025, complete its legal name change to "SonicStrategy Inc." pursuant to such filing (the "Name Change"). In connection with the Name Change, the Company will also change its ticker symbol on the Canadian Securities Exchange (the "CSE") from "SPTZ" to "SONI" (the "Ticker Change"). The Company's common shares ("Common Shares") are expected to begin trading on the CSE under the new name and ticker at market open on December 2, 2025. Under the Name Change, the CUSIP number assigned to the Common Shares is 83546W106 (ISIN: CA83546W1068). No action is required by existing shareholders, nor will any certificates representing Common Shares need to be exchanged. The articles of amendment concerning the Name Change will be available on the Company's SEDAR+ profile at www.sedarplus.ca. The Company's Name Change and Ticker Change have been approved by the CSE and unanimously approved by the Company's Board of Directors. This marks a new chapter for the Company as the name aligns with our long term goal of being a public markets access point for the Sonic blockchain. "This rebranding marks a pivotal milestone in our evolution," said Dustin Zinger, CEO of SonicStrategy. "At SonicStrategy, we're committed to building and operating high-performance validator infrastructure on the Sonic blockchain. We currently run two enterprise-grade validators, including the most self-staked validator in the entire Sonic ecosystem. At the same time, SonicStrategy is creating a transparent bridge between the Sonic blockchain and public markets, giving investors exposure to Sonic validators and DeFi protocols. The new ticker SONI reflects our focus on Sonic and our strategic vision going forward." For more information about SonicStrategy, visit www.sonicstrategy.io. About SonicStrategy Inc. SonicStrategy Inc. is the blockchain infrastructure subsidiary of Spetz Inc. (CSE: SONI) (OTCQB: DBKSF) (FSE: L6C). SonicStrategy is a blockchain company that (i) operates validators on the proof-of-stake Sonic blockchain, (ii) participates in decentralized finance ("DeFi") using its own assets, and (iii) holds Sonic Tokens on a long-term basis as part of its strategic treasury management of its Sonic Tokens. NEITHER THE CANADIAN SECURITIES EXCHANGE, NOR THEIR REGULATION SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Cautionary Note Regarding Forward-Looking Statements Certain information herein constitutes "forward-looking information" under Canadian securities laws, reflecting management's expectations regarding objectives, plans, strategies, future growth, results of operations, and business prospects of the Company. Words such as "may", "plans," "expects," "intends," "anticipates," "believes," and similar expressions identify forward-looking statements, which are qualified by the inherent risks and uncertainties surrounding future expectations. Forward-looking statements are based on a number of estimates and assumptions that, while considered reasonable by management, are subject to business, economic, and competitive uncertainties and contingencies. The Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from projected outcomes. Factors influencing these outcomes include economic conditions, regulatory developments, competition, capital availability, and business execution risks. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. The forward-looking information contained in this press release represents Spetz's expectations as of the date of this release and is subject to change. Spetz does not undertake any obligation to update forward-looking statements, except as required by law. This press release does not constitute an offer to sell or the solicitation of an offer to buy, and shall not constitute an offer, solicitation or sale in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction. None of the securities issued in the Private Placement will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. No securities regulatory authority has either approved or disapproved the contents of this press release. We seek Safe Harbor. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276211 |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:19
1mo ago
|
Samsung's Top Technicians Compete, Connect and Innovate at the 2025 National Skills & Repair Competition | stocknewsapi |
SSNLF
|
|
|
TORONTO--(BUSINESS WIRE)--Samsung hosted its National Skills & Repair Competitions, celebrating the top Mobile Experience and Consumer Electronics technicians.
|
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:25
1mo ago
|
Freehold Royalties Announces Departure of Chief Operating Officer | stocknewsapi |
FRHLF
|
|
|
November 27, 2025 16:25 ET
| Source: Freehold Royalties Ltd. CALGARY, Alberta, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. ("Freehold" or the "Company") (TSX:FRU) announces today the departure of Robert King, Chief Operating Officer, from the Company. "On behalf of the entire organization, I thank Mr. King for his dedication and the contributions made to advance our North American growth strategy over the last six years," said David Spyker, Chief Executive Officer. "We sincerely appreciate Mr. King's commitment to Freehold and wish him well in his future endeavors." As a result of Mr. King's departure, and in connection with the previously announced termination of the management agreement between the Company and Rife Resources Ltd., Freehold has decided to eliminate the Chief Operating Officer role, redistributing responsibilities across the existing executive team to align with the new operating structure. Freehold is uniquely positioned as a leading North American energy royalty company with approximately 6.1 million gross acres in Canada and approximately 1.2 million gross drilling acres in the United States. Freehold's common shares trade on the Toronto Stock Exchange in Canada under the symbol FRU. For further information contact Freehold Royalties Ltd. David SpykerShaina MorihiraPresident and Chief Executive OfficerVice President, Finance and Chief Financial Officert. 403.221.0809t. 403.221.0893e. [email protected]. [email protected] |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:29
1mo ago
|
StubHub (STUB) Slapped with Securities Lawsuit Over IPO Disclosures -- Hagens Berman | stocknewsapi |
STUB
|
|
|
Class Action Targets Offering Documents for Failure to Disclose "Known Trends" Adversely Affecting Operations and Liquidity
, /PRNewswire/ -- Ticket resale giant StubHub Holdings, Inc. (NYSE: STUB) is facing a proposed securities class action stemming from its highly anticipated initial public offering just weeks before it released disappointing third-quarter results. Hagens Berman is investigating whether StubHub's IPO materials were misleading and urges investors in StubHub who purchased or otherwise acquired company shares pursuant to the IPO or on the open market to submit your losses now. Class Period: Sept. 17, 2025 – Nov. 24, 2025 Lead Plaintiff Deadline: Jan. 23, 2026 Visit: www.hbsslaw.com/investor-fraud/stub Contact the Firm Now: [email protected] 844-916-0895 StubHub Holdings (STUB) Securities Class Action The lawsuit, styled Salabaj v. StubHub Holdings, Inc., et al., No 1:25-cv-09776 (S.D.N.Y.), seeks to represent investors who acquired common shares in the company's September 17, 2025, IPO. The offering saw StubHub issue approximately 34 million shares at $23.50 apiece. Allegations of Misrepresented Financial Health The litigation centers on allegations that StubHub's IPO offering documents were negligently prepared and contained untrue statements while failing to disclose crucial information to prospective investors. Specifically, the complaint alleges the company did not disclose "known trends, events or uncertainties" that were already having, or were likely to have, an adverse impact on StubHub's operations and key financial metrics. The plaintiffs highlight the company's strong emphasis on "free cash flow" in the offering documents, which the company positioned as a "meaningful indicator of liquidity for management and investors." This metric, according to the documents, was the amount of cash generated from operations that could be used for strategic initiatives. Post-IPO Plunge The narrative, according to the complaint, began to unravel on Nov. 13, 2025, when the company announced its Q3 2025 financial results. StubHub reported a negative free cash flow of $4.6 million, marking a staggering 143% decline from the prior year period. Net cash provided by operations plummeted to $3.8 million, a 69% decrease year-over-year. The company notably withheld Q4 2025 guidance, adding to investor uncertainty. StubHub attributed the decline to "changes in timing of payments to vendors." At the time of the earnings release, the company's CFO commented, "From the outset, we anticipated that 2025 would present a more challenging growth environment for our market." The news triggered an immediate and sharp reaction in the market. StubHub shares were driven down approximately 20% in the subsequent trading session, closing at $14.87—more than 36% below the initial $23.50 IPO price. Hagens Berman's Investigation Prominent shareholder rights firm Hagens Berman has opened an investigation into the alleged claims. The firm is specifically examining whether the IPO materials may have misled investors about the company's market opportunity, growth prospects, and the scope of its regulatory scrutiny. Reed Kathrein, the Hagens Berman partner leading the firm's investigation, commented on the situation, stating: "We're focused on whether StubHub's IPO materials may have misled investors about known trends in its business that, when disclosed in November, wiped out over $1 billion of market capitalization." If you invested in StubHub and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now » If you'd like answers to frequently asked questions about the StubHub case and our investigation, read more » Whistleblowers: Persons with non-public information regarding StubHub should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected]. About Hagens Berman Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. SOURCE Hagens Berman Sobol Shapiro LLP |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:30
1mo ago
|
2 Unstoppable Growth Stocks I'd Buy Now | stocknewsapi |
ACHR
JOBY
|
|
|
Both of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.
Flying cars have been a punchline for decades -- the technology that's always "just around the corner" but never arrives. That skepticism has created an opportunity. Electric vertical takeoff and landing (eVTOL) aircraft are no longer science fiction, and the two leading companies in this space have seen their stocks punished over the past month, despite making meaningful progress toward commercialization. This isn't a trade for anyone looking to flip shares next week. However, for investors willing to hold through volatility, the recent pullback in these names appears to be a gift. Image source: Getty Images. 1. The certification leader Joby Aviation (JOBY +1.29%) has emerged as the front-runner in the race to bring electric air taxis to market. The company is now in the final stage of Federal Aviation Administration (FAA) certification, having begun power-on testing of its first conforming aircraft. Management expects FAA test pilots to begin flying the aircraft early next year -- a critical milestone that would put Joby on track for commercial operations in 2026. The stock has pulled back roughly 35% from its 52-week high of nearly $21, resulting in a market capitalization of around $12.8 billion. That's a rich valuation for a company with minimal revenue, but Joby's partner roster suggests the smart money sees something real here. Today's Change ( 1.29 %) $ 0.18 Current Price $ 14.12 Toyota has invested nearly $900 million in Joby and is assisting in scaling its manufacturing operations. Nvidia is collaborating on autonomous flight systems through its IGX Thor platform -- making Joby the chipmaker's only partner in autonomous aviation. And Uber Technologies, which sold its eVTOL research arm to Joby, remains a strategic partner with a clear interest in integrating air taxis into its transportation network. Joby has completed over 600 flights this year, including two weeks of regularly scheduled demonstration flights at World Expo 2025 in Osaka, Japan. The company also recently announced a $250 million aircraft sale in Kazakhstan, signaling international demand is building even before certification. 2. The infrastructure play Archer Aviation (ACHR +1.49%) has taken a different approach, focusing on selling aircraft to operators while building out the physical infrastructure needed for urban air mobility -- short-haul flights within and between cities. The stock has been hit harder than Joby -- down roughly 34% over the past month and trading around $7.54 at the time of writing (Nov. 26), well below its 52-week high of around $14.6. But Archer has quietly assembled the pieces for a compelling long-term story. The company recently acquired Hawthorne Airport near Los Angeles for $126 million, securing a strategic hub less than three miles from LAX and close to SoFi Stadium. With the 2028 Olympics coming to Los Angeles, Archer is positioning itself to be the air taxi provider for one of the world's most congested cities. Today's Change ( 1.49 %) $ 0.11 Current Price $ 7.49 Archer's balance sheet is strong, with over $2 billion in liquidity providing years of runway. The company has also locked in major partnerships with Stellantis for manufacturing, United Airlines for aircraft purchases, and multiple carriers in Asia and the Middle East. Wall Street remains bullish despite the sell-off. The consensus price target is around $12.4 -- implying roughly a 70% upside from current levels if analysts are correct. Cathie Wood's Ark Invest has been adding shares amid weakness, a sign that at least one prominent growth investor views the pullback as an opportunity rather than a warning sign. The long game Neither Archer nor Joby is appropriate for investors who need near-term returns. Both companies are pre-profit, burning significant cash as they push toward certification and scale. The eVTOL industry faces real risks -- regulatory delays, manufacturing challenges, and the possibility that consumer adoption takes longer than expected. But the potential reward is enormous. Urban air mobility could become a multibillion-dollar market by the end of the decade, and these two companies have the partnerships, capital, and technology to lead it. The stocks that seem most volatile in the short term are often the ones that create the most wealth over the long term. For patient investors, the recent sell-off presents an opportunity worth considering. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:33
1mo ago
|
Sika AG (SXYAY) Shareholder/Analyst Call Transcript | stocknewsapi |
SKFOF
SXYAY
|
|
|
Sika AG (OTCPK:SXYAY) Shareholder/Analyst Call November 27, 2025 4:00 AM EST
Company Participants Dominik Slappnig - Head of Corporate Communications & Investor Relations Thomas Hasler - Chief Executive Officer Adrian Widmer - Chief Financial Officer Philippe Jost - Regional Manager of Asia/Pacific Christine Kukan - Head Investor Relations Conference Call Participants Cedar Ekblom - Morgan Stanley, Research Division Pujarini Ghosh - Sanford C. Bernstein & Co., LLC., Research Division Patrick Rafaisz - UBS Investment Bank, Research Division Priyal Mulji - Jefferies LLC, Research Division Presentation Dominik Slappnig Head of Corporate Communications & Investor Relations So good morning. It's a pleasure to welcome you today to our Fast Forward Media Investor Conference. With me today on the stage is Thomas Hasler, our CEO; Adrian Widmer, our CFO; and Philippe Jost, our Manager, Asia Pacific. As well present today, here in the room is our chair, Thierry Vanlancker; and the members of our group management. Thank you very much to be here as well. With this, I hand over to Thomas to start the conference. Thomas Hasler Chief Executive Officer Good. Thank you, and also a warm welcome from my side. And for all the guests from far and near. And also the online participants here, a special welcome to the early birds in the U.S. that have a very long Thanksgiving today. So that's the good part, but it's 4 a.m. to join this next 90 minutes. I would also like to welcome my team, colleagues, employees of the Sika Group, and it is them that enables us here in front to present a strong Sika with clear way forward and clarity on the Fast Forward program that we will comment in the coming 60 minutes. But I would like also, before we go into the program, talk about the foundation of Sika a little bit. It's a foundation from Recommended For You |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:35
1mo ago
|
ROSEN, SKILLED INVESTOR RIGHTS COUNSEL, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO | stocknewsapi |
PRGO
|
|
|
November 27, 2025 4:35 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. SO WHAT: If you purchased Perrigo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Perrigo. class action, go to https://rosenlegal.com/submit-form/?case_id=48085 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance; (2) Perrigo needed to make substantial capital and operational expenditures above Perrigo's outwardly stated cost estimates to remediate the infant formula business; (3) there were significant manufacturing deficiencies in the facility for Perrigo's infant formula business; (4) as a result of the foregoing, Perrigo's financial results, including earnings and cash flow, were overstated; and (5) as a result of the foregoing, defendants' positive statements about Perrigo's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Perrigo class action, go to https://rosenlegal.com/submit-form/?case_id=48085 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276074 |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:40
1mo ago
|
Falling rates, USD and crypto will propel gold's next leg higher – Wells Fargo's Samana | stocknewsapi |
AAAU
BAR
DBP
DGL
GLD
GLDM
IAU
OUNZ
SGOL
UGL
|
|
|
Kitco News
The Leading News Source in Precious Metals Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments. |
|||||
|
2025-11-27 22:00
1mo ago
|
2025-11-27 16:54
1mo ago
|
ATEX Provides Corporate Update | stocknewsapi |
ATXRF
|
|
|
DTC Eligibility Secured Enhancing Liquidity of ATEX Shares in U.S. Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - ATEX Resources Inc. (TSXV: ATX) (OTCQB: ATXRF) ("ATEX" or the "Company") is pleased to announce that in accordance with its Stock Option Plan, it has granted an aggregate of 1,994,261 incentive stock options to employees of which 990,245 have been granted to officers. Each option entitles the holder to acquire one ATEX common share at an exercise price of $2.60 over a period of five years and will vest one third on each of the first, second and third anniversaries of the grant date in accordance with the Company's Stock Option Plan.
|
|||||